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A notable measure of the values and ethos of any society is its
treatment of those who are weakest and most vulnerable and there
can be no more vulnerable group than homeless drug addicts.
Therefore, we especially welcome the peer-reviewed paper on ‘Oral
health behaviours amongst homeless people attending rehabilitation
services in Ireland’ published in this edition (pp144-149). Dr Marie
Claire Van Hout of Waterford Institute of Technology and Evelyn
Hearne of the Dublin Simon Community are to be congratulated on
their research with individuals who were either in detoxification,
rehabilitation or maintenance programmes.
Their findings echo previous research outside of Ireland, which
indicates the low uptake of dental services amongst such individuals.
It also highlights how self-consciousness and guilt around dental
neglect impacts on the recovering addict’s self-perception and
potential for employability. On the positive side, it is evident that
preventative care improves when the individuals are attending
treatment and rehabilitation and that for those in recovery, specific
dental interventions would be received positively.
The study calls for further research and we heartily endorse that call.
Meanwhile, the Journal has just been made aware of a recent initiative
by dentists to make dental care more easily accessible to the homeless
in Dublin. We welcome this initiative and will report on it in future
editions.
Clinical education
In the second of our clinical features, Dr Maurice Fitzgerald of
Sandyford in Dublin outlines a step-by-step technique for building up
an accurate mandibular impression (pp122-125). Given that the
edentulous mandibular arch can be a difficult impression to make, this
is a most practical and helpful guide. Dr Fitzgerald’s provision of 16
photographs to illustrate the 11 steps that he describes makes for an
easy-to-follow guide, for which the Journal is grateful.
CPD central
There is no doubt that the occasion of an IDA Annual Conference is a
veritable treasure trove of continuing professional development. From
the pre-Conference ‘hands-on’ courses to the presentations on all
aspects of dentistry, there were learning experiences to be had in all
lecture and conference rooms. The Journal can only bring a flavour of
the proceedings, but does so once again on pp127-128. That such an
important learning event has such a successful social aspect makes it
a compelling experience.
In addition, there is the AGM and business of the Association to be
conducted. Dr Barry Harrington and Mary Graham were the recipients
of well-warranted recognition, while Dr Seán Malone passed the chain
of office to Dr Peter Gannon, who we welcome in his first President’s
message in this edition.
Forensics
In our interview, we learn of some of the more difficult cases that
dental forensics expert Professor David Whittaker has encountered.
There can be no doubt that David advanced the science of forensic
dentistry very significantly throughout his career and those who heard
him speak in Kilkenny were privileged to do so. His fascination with
Hitler’s remains also makes for quite a story.
Sensodyne and the Journal
We are, as always, very grateful to all our advertisers for their
continuing support. All research shows that the Journal offers
advertisers the best place to advertise to dentists in Ireland.
Back in 2008, we set out in a very modest way to explore the notion
of facilitating patients in expressing appreciation of the oral healthcare
they receive from their dentists. With GSK, we entered completely
unchartered territory with the Sensodyne Sensitive Dentist of the Year
Awards. In our first year, we were thrilled to receive several hundred
entries testifying to the great work of Irish dentists. Over the years
since, the volume of entry has multiplied and the task of judging has
become ever more challenging. Now in 2014, we are set to move up
another gear in tandem with Sensodyne, with the announcement that
there will be a Gala Awards Ceremony in Dublin to mark the
culmination of this year’s programme. We look forward to, once
again, showcasing the superb work of Irish dentists as testified to by
their patients.
This is another packed Journal and I trust that you will both learn from
it and enjoy its contents.
Editorial
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Prof. Leo F. A. Stassen
Honorary Editor
Caring for the weak; and recognising great care
Honorary Editor, PROFESSOR LEO STASSEN, welcomes a scientific paper with an important social
aspect; recommends the clinical feature; and, looks forward to a development in the Sensodyne
Sensitive Dentist of the Year Awards.
It is a great honour to write my first President’s news
for the Journal of the Irish Dental Association and I
will endeavour to serve you as best I can for the
coming year as President of the Association. 
IDA Annual Conference 2014 
I would like to thank all of the delegates who
participated in this year’s Annual Conference in
Kilkenny. It was a resounding success and thoroughly
enjoyed by all. We had first-rate speakers, both from
home and further afield, and the calibre of the talks,
courses, and presentations was excellent. Special
thanks also to our trade sponsors, whose support we
are very grateful for. Thank you and congratulations
to the members of the conference organising
committee – Ms Elaine Hughes, Drs Billy Davis,
Naomi Richardson, Tom Rodgers, and Alastair
Woods.
The Dental Act
One of the most significant matters in the upcoming
year that I will face as President is the introduction of
the new dental legislation. 
The Association and Council members have engaged
with the Department of Health to raise key issues on
behalf of members and continue to lobby for
compulsory CPD, foundation training, licensing of
practices, and recognition of specialists.
It remains unclear when the legislation will come into
effect, however, I feel confident that the new Dental
Act will be of benefit to our profession. 
The Dental Complaints Resolution Service (DCRS)
May saw the launch of the second annual report of
the DCRS. Since its inception, the DCRS has been
very busy and I believe it is a progressive and
worthwhile initiative. 
The more complaints that can be settled in
this way, the less litigation there will be and
our DPL yearly payments will ultimately
reduce. 
Fluoridation
The Association continues to endorse water
fluoridation as the most practical, cost-
effective, and safe public health measure to
control the occurrence of tooth decay
in Ireland and I will endeavour to
further promote this issue and
raise awareness over my term as
President. 
Time to recharge
Sincere thanks for appointing
me as your President. I look
forward to meeting as many
of you as possible over the
next 12 months. May I also
take this opportunity to wish
you all a safe and sunny
summer. I hope you and
your team manage to get
a well-deserved break
over the summer months
and come back in the
autumn refreshed and
recharged.
Dr Peter Gannon
IDA President
President’s news
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An exciting year ahead
Incoming President Peter Gannon looks forward to the year ahead, and to the issues 
he hopes to tackle. 

Letter to the Editor
Dear Sir,
Representatives of Mouth Cancer Awareness Ireland attended the Irish
Pharmacy Union (IPU) Conference on Saturday, May 10 in Cavan. The
representatives had an information stand which was very kindly
sponsored by the IPU. The purpose of attending the IPU Conference
was primarily to heighten awareness amongst pharmacists about the
risks and symptoms of mouth cancer and secondly to publicise the
upcoming Mouth Cancer Awareness Day, which takes place on
September 17, 2014.
Integrating primary care and oral health and increased collaboration
between dental and all other health professionals means improving
the rate of early detection of conditions such as mouth cancer. Early
detection greatly improves the chance of successful treatment and
saves lives.
This holistic approach to oral health is in line with goals one and two
of Healthy Ireland, i.e., addressing risk factors and promoting
protective factors at every stage of life and implementing
interventions to target particular health risks.
Yours faithfully,
Ms Etain Kett
Acting Chief Executive, Dental Health Foundation
(Member, Mouth Cancer Awareness Ireland).
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Ms Etain Kett (left) and
Dr Denise MacCarthy
(right) representing
Mouth Cancer Awareness
Ireland at the Irish
Pharmacy Union Annual
Conference with 
Dr Catriona Bradley,
Executive Director, Irish
Institute of Pharmacy.
Media coverage of dental fees
The Sunday Business Post (SBP) recently compared prices for dental
fees in the Republic with those in Northern Ireland.  The Association
was concerned about some of the comparisons and made its own
enquiries in regard to the prices charged for different types of crowns
on both sides of the border.
Chief Executive Fintan Hourihan responded in writing to the paper to
state: “I must disagree strongly with most if not all of the conclusions
and inferences drawn from the ‘survey’ of dental fees published in the
most recent edition of the Sunday Business Post (April 27th edition).
“All the northern practices featured are based in smaller towns. It is
misleading and unfair to contrast these with city-centre practices in
Dublin and Cork, where running costs are greatest. A quick review
online of fees in southern towns reveals prices at very similar levels for
treatments across the border.  
“The most common treatment for patients is an oral examination and
cleaning of the teeth. These are also the most important treatments in
ensuring long-term oral health. This is not mentioned at all. For these
treatments the difference in fees north and south is often very slight.  
“Tooth whitening and fitting sports mouth guards are just two of the
treatments which online searches indicate to be cheaper south of the
border. Again, these were not mentioned.
“Many readers recognise quality in choosing to buy newspapers
published in the Republic of Ireland, which can be almost three times
more expensive than alternative titles. Our experience is that patients
ultimately choose a dentist based on the quality of care they offer, the
friendly and expert advice they offer, and the convenience and peace
of mind offered by local dentists in their community. It is reassuring to
report that 95% of Irish adults say they trust the care provided by Irish
dentists, according to research amongst 750 adults carried out last
year by Behaviours and Attitudes.
“Recent independent research of the adult population (September,
2013) shows that, currently, adults have been with the same dentist
for 11.5 years on average.
“Despite the advent of greater advertising, websites and social media,
most patients choose a dentist on the basis of a personal
recommendation. The biggest savings in dental costs are always
achieved by simple measures at home and by regular, preventive
dental visits.
“Clearly, there is scope for confusion and as a result it can be very
difficult to compare like with like. When there is an actual like for
like comparison, the fees charged south of the border are actually
just as competitive. Thus, the original report caused upset to
dentists in the Republic and this has been communicated to the
Sunday Business Post.”


Moore wins Moloney Award
Julius Morris Green was born in 1912 and spent his early childhood in
Killarney where his father had a dental practice. He studied at the
Dental School of the Royal College of Surgeons in Edinburgh and was
practising in Glasgow when he joined the Territorial Army in 1939,
being posted to the 152 (H) Field Ambulance of the 51 Highland
Division. He was captured with his brigade at St Valery in June 1940
and spent the remainder of the war in a succession of camps, his
misbehaviour meaning that he eventually received the honour of
being confined to Oflag IV-C, better known as Colditz.
Papers, photographs and the effects of Captain Green of the British
Army Dental Corps, relating to his espionage activities on behalf of the
British Directorate of Military Intelligence while a prisoner-of-war at
Colditz and other camps in Germany, will be sold at Bonhams Auction
House in Knightsbridge, London in June. The risks he was running, as
a Jewish prisoner-of-war in Nazi hands, were enormous. Estimates for
the material range from stg£4,000 to stg£6,000.
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Quiz questions
Submitted by Dr Mark Kelly
A 30-year-old fit and healthy female attends the surgery
complaining of general malaise and severe discomfort in the upper-
right molar region for the past three days. She put her finger on UR6
as the perceived source of the pain and is convinced her problem is
a dental one. The pain is spontaneous, ‘sharp and stabbing’ in
character, and is becoming gradually worse. The patient also feels
pain around her right eye. She noticed a rash recently developing on
her right forehead and above her upper right eyelid (Figure 1). The
UR6 (Figure 2) has an amalgam filling in situ (placed many years
ago), which appears clinically sound.
Questions:
1. What is the most likely cause of this woman’s pain?
2. What course of action would you take?
Figure 1
Figure 2
Answer
page 151
The author wishes to thank his patient for kindly allowing 
her photograph to be used to highlight this case.
At this year’s IDA
Annual
Conference, Dr
Paul Moore of
Gate Dental
Clinic in Galway
was the winner
of the Moloney
Award.
Dr Julius Green attending a patient.
The Killarney
dentist in
Colditz
Diplomates in Primary Dental Care
The first group of Diplomates of Primary Care Dentistry RCSI were
conferred at the RCSI in December 2013.
The first sitting of the Diploma was held in October 2013. Fourteen
candidates sat the examination and each was successful on their first
attempt. The Faculty was delighted to welcome its first group of
Diplomates to the winter conferring in December 2013. Apart from
being a new qualification, this graduation carried special significance
for the Faculty of Dentistry at RCSI, which celebrated its 50th
anniversary in 2013 (1963 – 2013).
The Diploma of Primary Care Dentistry has been approved by the
Dental Council and the examination has been developed by the
Faculty of Dentistry RCSI in collaboration with the Irish Dental
Association and the Irish Faculty of Primary Dental Care. Candidates
who are successful in the Dip PCD RCSI may enter the MFD Part 2
directly (and are exempt the MFD Part 1) provided they meet all the
requirements as set out in the regulations. The Diploma of Primary
Care Dentistry, RCSI is also a stand-alone qualification.
A recent sitting of the Diploma examination was held in early April
2014. For those who may be interested, the next sitting of the
Diploma examination will be in October 2014 at RCSI. The
examination consists of an MCQ examination and a clinical reasoning
assessment, which will take the form of a written paper. There will be
a strong emphasis on clinical practice within both components of this
examination. Further information, including regulations and the exam
closing date, can be found on http://dentistry.rcsi.ie or by emailing
facdentistry@rcsi.ie. The Faculty of Dentistry RCSI also runs a monthly
Postgraduate Dental Education Programme, which provides a
considerable amount of information that is relevant in helping
candidates to prepare for this examination. 
Prize winners
Meanwhile, the Faculty of Dentistry in RCSI also offers a number of
prizes to recognise and support achievement of future members of the
dental profession. 
In 2013, the Faculty was delighted to honour the following dental
students and trainees:
n The Adrian Cowan Medal was awarded to Mr Ronan John O’Leary,
the best all-round fourth year dental student at the Dublin Dental
University Hospital. 
n The Leo Heslin Memorial Medal was awarded to Mr Ahmed Sultan,
a fourth year dental student at the Dublin Dental University
Hospital.
n The John McGimpsey Prize was awarded to Ms Emily Lovegreen,
who achieved first place in the Final BDS Examination at Queen’s
University Belfast.
n The (inaugural) Seamus Keating Prize was awarded to Ms Orna Ní
Choileáin, who achieved first place in the Final BDS Examination in
Child Dental Health at University College Cork. 
n The RCSI/ IADR Postgraduate Clinical Research Award was awarded
to Dr Emma Warren, Graduate Oral Surgery Programme, Cork
University Dental School.
The first four prizes are named after leaders in dentistry in Ireland who
made significant contributions to dentistry in general, and to the
Faculty in particular. They were also noted as outstanding teachers
who made a special effort to encourage excellence among dental
students and young dentists.
News
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From left: Professor Gerard Kearns (Past Dean); Dr Liam Jones
DipPCD RCSI; Dr Frank Ormsby (Irish Faculty of Primary Dental
Care); Dr Osama Omer (Vice Dean); Dr Tony Markus (Ad Eundem
FFD); Dr John Walsh (Dean). (Image courtesy of Ms Maria Jones).
Dental graduates at
winter conferring
RCSI, including
representatives of
Faculty of Dentistry
RCSI, Irish Dental
Association, and Irish
Faculty of Primary
Dental Care.

The search is on
Sensodyne and the Journal have teamed up again
this year for the premier award in Irish dentistry –
the Sensodyne Sensitive Dentist of the Year.
The search is on again for the Sensodyne Sensitive Dentist of the Year,
in association with the Journal of the Irish Dental Association. No self-
nomination will suffice here. No notion of most attractive this or that.
This is just about the dentistry and the care dentists give to patients.
Chairman of the judging panel, Dr Barry Harrington, has stated that
he has never seen, in his years in dentistry, such a bank of fantastic
testimony to the standard of work and care by Irish dentists. And this
year there is going to be a new development: dentists that are
nominated are going to have the opportunity to attend the Awards
Ceremony in Dublin. 
Dentists are invited to register for the Awards by returning the prepaid
postcard on the wrap around this edition of the Journal. Alternatively,
just get in touch with GSK at their headquarters in Stonemasons Lane
in Rathfarnham in Dublin.
Your patients do need your permission to enter – but the incentive is
fantastic. The nominator of the winning dentist will receive a prize of
a family holiday to the value of €5,000. In the event that there is more
than one nomination of the winning dentist, the winning nomination
will be decided by the judging panel. The competition is open to
Republic of Ireland patients aged 18 or over only and the closing date
for nominations is October 31. 
Three ways to be nominated
Entering is simple. Patients just have to describe, in their own words,
what it is that their dentist did for them that they consider above and
beyond the normal duty of care. Patients can do this in three ways:
they can post in an entry form that will be available in your waiting
rooms (if you have registered to take part); patients can fill in the form
on the competition website www.sensodynesensitivedentist.ie; or,
patients can fi l l  in the form on the Facebook page
www.facebook.com/dentalhealthalliance.
New Awards Ceremony
In a new departure, this year there is going to be a Gala Awards
Ceremony to announce the winners. It promises to be a fantastic
occasion when dentists from all parts of Ireland will gather to
celebrate the fact that their patients have nominated them to receive
an award. Details of the date and venue will be announced in
forthcoming editions of the Journal.
Launch
The Awards were formally launched at the Association’s Annual
Conference in Kilkenny in May. At the launch, Paul Hatton of GSK,
makers of Sensodyne, said that the Awards are part of Sensodyne’s
commitment to better oral health and an important aspect of the
company’s engagement with the dental profession. He looked forward
to a successful development of the Awards this year. Paul O’Grady,
speaking on behalf of the Journal, thanked Sensodyne for their
outstanding commitment to developing a programme that
commenced in 2008 and which has grown very significantly since then.
Business news
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At the launch of the Sensodyne Sensitive Dentist of the Year were
(from left): Dr Peter Gannon, President of the Association; with
GSK executives Claudia Long; Jennifer Valentine; Paul Hatton; and,
Eilís Tobin.
Dr Johnny Walker at NIDM
Recently a group of specialist practitioners attended the
Northumberland Institute to hear Dr Johnny Walker speak on his latest
initiative ‘Jinga Life’ - a mobile, digital, 24/7, home-based and
personalised health solution. It is aimed at empowering and enabling
the parents at the centre of family healthcare needs. How this
technology is tailored for the dental profession was part of the focus
of the evening.
Dr Anne O’Donoghoe introducing Dr Johnny Walker.
Business news
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New from Voco
According to Voco, Futurabond M+ is the universal
adhesive in bottles that scores on content, reliability
and abilities. The company states: “Futurabond M+
offers the user flexible solutions for every bonding
situation. This applies to the etching technique: total-
etch, selective-etch or self-etch – the dentist is free to
choose and apply the etching technique, depending
on indication or according to personal preference.
Thanks to a new type of monomer technology,
overetching of the dentine is impossible, which prevents post-
operative sensitivity. Futurabond M+ is also considerably more
flexible than conventional bottled bonding agents with regard to its
spectrum of application: not only can it be used reliably for direct
and indirect restorations, but it also offers secure adhesion to various
materials such as metals, zirconium or aluminium oxide, as well as
silicate ceramics – and it requires no additional primer.”
Voco has also launched IonoStar Molar, which is a newly-developed
glass ionomer restorative material which comes in the new VOCO
application capsules. The material is applied without conditioner or
adhesive and the company claims it scores particularly highly thanks
to its non-sticky consistency and perfect marginal adaptation. It
states: “IonoStar Molar can be modelled immediately after insertion
and cures within four minutes. Its lastingly high level of fluoride
release counteracts post-operative sensitivity. In conjunction with
Easy Glaze, the nano-filled protective coating for surface sealing,
IonoStar Molar can be used to quickly and easily create restorations
that are as aesthetic as they are durable.”
Southern Cross Dental unveils rebrand
Southern Cross Dental Laboratories has been meeting the laboratory
needs of dentists throughout Ireland for over a decade. Early May
saw the announcement of the company’s decision to rebrand under
the more succinct name of Southern Cross Dental. “The decision to
rebrand largely came from listening to what our customers require,”
explains Managing Director, David Reaney (right), “We found that
dentists often needed more than just a basic laboratory service. This
is why we wanted to re-introduce our organisation as Southern Cross
Dental, demonstrating our focus on being more than just a
laboratory by providing streamlined solutions for our customers.” 
New services
As part of the rebranding process, Southern Cross Dental also
launched a new user-friendly website, scdlab.co.uk. Southern Cross
Dental plan to introduce a wholly interactive platform for their
customers within the next few
months, with new features and
customer functions to be added that
will enhance the customer experience
further. 
Guarantee
David Reaney is keen to point out that
the company rebrand is reflective of
the evolution of Southern Cross
Dental: “You can be assured
rebranding does not mean we will be
turning away from any of the values that are so integral to our
success. Reliability and quality will remain at our core, however, it is
through the experience and innovation of our people that we will see
some really exciting things start to happen within the profession.” 
Business news
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Colgate has launched
what it says is a ground-
breaking new Maximum
Cavity Protection
Toothpaste plus Sugar
Acid Neutraliser
Toothpaste. It aims to set
a new standard of care in
everyday cavity protection
for individuals and families, and provide a new approach to address a
major oral health challenge. Despite advances in caries prevention due
to the inclusion of fluoride in daily toothpastes, dental caries remain a
widespread problem. Children and teenagers are at increased risk of
caries. As children grow older and gain more independence, free
sugar (e.g., glucose) consumption in their diet and repeated snacking
can increase, whilst at the same time they can become less careful
about their oral health as parental supervision decreases. 
Colgate Maximum Cavity Protection plus Sugar Acid Neutraliser
Toothpaste directly targets acids produced from free sugar in plaque.
Supported by eight years of clinical research involving 14,000
subjects, the technology has been clinically proven to provide greater
cavity protection versus regular everyday fluoride toothpaste. The
breakdown of dietary free sugars by some plaque bacteria produces
acids. Colgate’s unique Sugar Acid Neutraliser technology uses
arginine, a naturally occurring amino acid. The arginine is metabolised
by other plaque bacteria, which helps to neutralise the damaging
acids produced by the breakdown of dietary free sugars, helping to
restore pH in the plaque biofilm to a more neutral and healthier level. 
Colgate Maximum Cavity Protection plus Sugar Acid Neutraliser
provides an effective everyday
solution for the whole family to
help fight the development of
caries now and in years to come. All
variants in this new toothpaste
range contain 1450 ppm fluoride,
including a kid’s variant which
benefits from a milder mint flavour to make it
more acceptable to younger children. To find out more
information, please visit and register at
www.colgateprofessional.co.uk
Special learning broadcast
Meanwhile, Colgate invites dentists to view a special learning
broadcast delivered by Professor David Bartlett - Head of
Prosthodontics at King’s College London Dental Institute. In this
broadcast, you have the opportunity to learn how you can further
help your patients with dentine hypersensitivity. Simply view,  give
feedback and complete CPD questions to gain one hour CPD.
Dentine hypersensitivity is a painful yet common oral health
problem. During this broadcast, Professor Bartlett provides an
interesting and informative overview in which he discusses his
personal experiences of dentine hypersensitivity and how his own
perceptions around risk factors have evolved. The broadcast also
looks at an overview, including epidemiology and aetiology before
moving to reviewing measurement methods and underlying
conditions as contributing factors. Towards the end of the hour,
Professor Bartlett looks at available technologies and treatment
options based on the previously highlighted underlying conditions,
whilst sharing some interesting case studies reviewing simple,
complex and resistant cases. To view this complimentary broadcast
visit http://www.colgate professional.co.uk/professional
education/DHS-in-the-Dental-Surgery-1-hour-verifiable-CPD/video. 
Take the Instant Relief Challenge 
Dental professionals attending the Dentistry Show in the UK joined
over 51,000 participants who have already completed the Instant
Relief Challenge using Colgate Sensitive Pro-Relief Toothpaste.
Members of the dental team who suffer from dentine
hypersensitivity had the opportunity to take part in the Instant Relief
Challenge, which kicked off with sufferers drinking a glass of cold
water ladened with ice cubes. Those who experienced the pain of
sensitive teeth were invited to apply Colgate Sensitive Pro-Relief
Toothpaste directly to their sensitive teeth for one minute. After this
time they took another drink of ice cold water to compare the
experience prior to using the toothpaste. 
According to Colgate, of the participants who have taken the
challenge to date, 83% stated Colgate Sensitive Pro-Relief
Toothpaste was effective in providing instant sensitivity relief and
81% agreed it was effective in providing lasting protection. Dentists
can ask their patients with dentine hypersensitivity to take the
challenge by visiting www.colgatesensitiveprorelief.co.uk.
Colgate launches new Maximum Cavity Protection Toothpaste

The mandibular edentulous arch can be a
most difficult impression to make during
complete denture construction. Ill-fitting
lower complete dentures are often a source of
discomfort for patients. While implant
retention helps to achieve vertical stability,
unless a completely implant-supported
denture is being made, the denture must
have good tissue contact and correct
anatomical extension. An impression
technique is required that captures the
denture-bearing areas, but also allows
compression of the tissues in accordance with
their relative nobilities.1,2,3 
Loose tissues require a mucostatic
(uncompressed) technique, whilst immobile
tissues are best util ised with a
mucocompressive (loaded) impression
technique. This leads to a denture that
differentially loads the area best able to
support masticatory forces. There are a
number of means to achieve this selective
pressure. The use of impression compounds
and Zinc Oxide Eugenol impression materials
are classically advocated. However, in a busy
practice, the use of various viscosities of
polyvinylsiloxane (PVS) is convenient,
accurate, dimensionally stable, fast setting,
easily adjusted and added to, elastic when
drawn over undercuts, dimensionally stable
during transport, well tolerated by the
patient, and time efficient.4
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FIGURE 1: The uncompressed ridges.
Implants are present in this case, however
the technique is identical for conventional
complete dentures.
FIGURE 2: The mobility of the tissues is
tested and mobile areas noted. Here the
anterior region is mobile.
FIGURE 6: Mounting plaster is fast setting
and suitable for edentulous impression.
FIGURE 7: The impression is cast in plaster
and set in a base former.
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A build-up impression technique for the
edentulous mandible using various
viscosities of silicone impression material
Below is a step-by-step method for building up of an accurate,
functionally extended mandibular impression. This technique also
works equally well for maxillary impressions and impressions for partial
dentures. This technique is similar to that published by Massad,5
however the “Massad technique” utilises prefabricated stock trays. It is
this author’s opinion that using rapidly fabricated custom trays gives
the dentist greater control, less use of impression material, and leads to
less overextension and less distortion of the dimensions of the sulcus.
No particular brand of impression material is advocated, so long as
various viscosities are used. All PVS materials will bond to each other
when dry.
STEP Primary and secondary impressions are taken at the same
visit. The patient is instructed to discontinue wearing any existing
prosthesis for 12-24 hours prior to the appointment, to allow the oral
tissues to rebound and ensure an accurate impression of uncompressed
tissues. If the existing denture is causing tissue problems, tissue
conditioners or reline material may be used to restore health. The ideal
representation of the denture bearing areas is borne in mind
throughout the procedure, however, patients rarely conform exactly to
this ideal, unless the dentist overextends the impression material
(Figure 1).
STEP The patient’s oral mucosa is examined. Two blunt
instruments are used to measure the relative mobility of tissue areas.
Compressible or mobile areas are noted (Figure 2).
STEP An alginate impression is made in a correctly sized edentulous
stock tray. This impression will certainly be overextended and minimal
efforts should be made to functionally mould this impression. Some tray
show through is normal, but highly-inaccurate impressions or poorly-
seated impressions should be discarded (Figures 3 and 4).
STEP In order to quickly achieve a custom tray that is short of the
anatomical boarders, the alginate is cut back with a scalpel 3-4mm
circumferentially. This impression is cast with fast-setting stone.
Mounting plaster is extremely fast to set, especially when mixed with
warm water. It comes in individual sachets, which is conveniant for
the general dental surgery. Excess plaster should be allow set in the
mixing bowl and not discarded down a sink, unless a plaster trap in
situ (Figure 5).
STEP After five minutes the stone will be set and warm to the
touch. The impression is removed. A pencil is used to mark the
extension of the custom tray. Any large undercuts can be blocked out
with blu-tack or wax. Tray material should extend to the base of the
sulcus on the cast, half way up the retromolar pad, and into the
sublingual space. A sheet of light-cured custom tray material is
adapted to the cast and pressed into the sulcus. The pencil mark will
be visible through the tray material, and a scalpel is used to trace
around the pencil line. The excess tray material is removed, rolled into
a sausage shape and adapted to the tray as both a vertical handle and
reinforcement (Figures 6 to 10).
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FIGURE 3: A stock edentulous tray is sized. FIGURE 4: A good but overextended
primary impression.
FIGURE 5: The boarders are removed from
the impression to ensure the custom tray
will be short of the borders.
FIGURE 8: Once set, the cast is marked for
proper tray extension.
FIGURE 9: The tray material is rapidly
adapted to the cast and trimmed.
FIGURE 10: A curing light is used to
polymerise the material. Note the shape of
the handle so as not to interfere with
moulding movements intraorally.
1
2
3
4
5
STEP A composite curing light will rapidly set the tray material.
The tray will not stick to the cast once set. The pencil mark will transfer
to the set tray material and the tray can be trimmed to ensure the
boarders are not overextended. The final tray should be left
unpolished to help retain impression material. Perforations are not
placed in the tray. The tray should be disinfected (Figure 11).
STEP The patient is returned to the dental chair, having been
waiting 10-15 minutes for tray construction. The tray is tried into the
patient’s mouth to ensure it is comfortable and not overextended
during functional movements. Tissue stops are necessary to space the
tray away from the tissues. Bite registration silicone is useful for this.
Three small amounts are expressed onto the tray (spots of PVS
adhesive can be used to ensure it sticks) and the tray seated into the
mouth with as little pressure as possible. After setting, the silicone
stops are trimmed into neat areas away from the boarders (Figures 12
and 13).
STEP A heavy viscosity (heavy body or putty consistency) silicone
is mixed into a disposable syringe. PVS adhesive is painted around
only the boarders of the tray. The silicone is injected only around the
boarders and seated carefully in the mouth. The functional
movements are made to capture the border extension. Upon removal,
excess is trimmed with a scalpel. Further heavy bodied silicone can be
added to areas and remoulded in the mouth if necessary. Folds, voids,
and air blows in this increment are irrelevant. If the tray shows
through the boarder, cut back the tray in that area and move to the
next step (Figures 14 and 15).
STEP Any exposed areas of tray are covered with PVS adhesive.
Light viscosity silicone is added to the tray in the incompressible areas
and ultralight silicone in any compressible areas. The tray is re- seated
with force in the mouth and the functional movements carried out
repeatedly until the material is set. If there are any deficiencies,
another wash of ultralight can be made over the entire impression.
Avoid adding only small areas of silicone. A total wash over the
impression will avoid uneven seating of the tray, the differential
elasticity of the deeper layers will maintain the selective pressure
(Figures 16 and 17).
STEP The final impression is dried and inspected. All the denture
bearing areas should be captured and the boarders should be
rounded and narrow. Any areas that do not conform to the image of
an idea impression should be inspected in the mouth to see if they
accurately represent the patient’s anatomy. If there are major issues
with the impression, peel the PVS from the tray and start over (Figure
18).
STEP The dentist should prescribe the laboratory box and bead
the impression to transfer the impression accurately. This is
particularly important in regard to capturing the sulcus width. Figure
19 shows the final prosthesis and recreated the boarders in all
dimensions.
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FIGURE 11: The tray is trimmed and
smoothed.
FIGURE 17: The tray is returned to the
mouth and boarder moulded many times
until the PVS is fully set.
FIGURE 12: Occlusal registration silicone
used to space the tray.
FIGURE 18: The final impression.
FIGURE 13: Spacers are trimmed away from
boarders.
FIGURE 19: The final denture.
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FIGURE 14: Heavy viscosity PVS is syringed
around the adhesed borders.
FIGURE 15: Boarders moulded intraorally. FIGURE 16: Ultralight PVS used in the
mobile regions and light bodies in the
immobile regions. Two guns are required
to express the material rapidly enough to
avoid premature setting.

Dr Nick Armstrong got the jam-packed team programme underway
on Friday morning with his presentation on infection control and
washer disinfectors. In a short presentation, Nick talked delegates
through the importance of correct instrument washing and
disinfection. The most important message he had for the audience
was to always read the manufacturer’s instructions when it comes to
cleaning equipment. 
If anyone was still feeling lethargic by 9.30am, Dr Conor McAlister
was not making allowances for it. During his interactive presentation
on Irish dental project in Africa ‘Cheka’, he challenged delegates to
get involved and answer questions. Their efforts did not go
unrewarded, as Conor provided prize bracelets for those who
answered correctly. 
The Cheka project is run in the town of Embulbul, located 20km
outside Nairobi in Kenya. The project began in 2002, and Cheka
opened a dental surgery in Embulbul in 2003. Since its foundation,
14 teams of volunteers have visited Nairobi as part of the project. 
Delegates passing by outside the conference hall could be forgiven
for thinking there was some kind of celebration going on inside, as
the presentation concluded with a slideshow of photographs, to the
music of Bob McFerrin’s ‘Don’t worry, be happy’.
Putting on your thinking hat
Director of Dental Protection, Dr Kevin Lewis (pictured above right)
was the third speaker of the morning, giving an address on simple
steps members of the dental profession can take to reduce the risk of
litigation. In an entertaining presentation, Kevin referenced statistics
that show that New Zealand is the least litigious country for dentists,
because the government compensates patients for any harm they
might suffer during the dental process. However, in Ireland, claims
are much bigger, and Dental Protection saw a massive rise in
litigation when the recession hit. 
Kevin adopted Edward de Bono’s ‘six thinking hats’ tool as a method
of helping the dental team avoid litigation. The group-thinking tool
allows the dentist to look at a situation from six different angles -
facts, emotions, threats, opportunities, innovation, rational – in order
to determine the risk, and solve it before it becomes an issue. 
Healthy tips for patient and dental team
Following the morning break, hygienist Kellie O’Shaughnessy took to
the podium to discuss oral health promotion. Kellie’s presentation
emphasised the importance of communication with patients: “The
moment the patient walks through the door, communication is key.
Not just verbal contact, but also body language and eye contact.” 
Kellie went on to discuss how approaching a patient in a positive way
about oral health can make all the difference. To prove this point,
delegates were shown two different videos of the same scenario –
discussing the issue of smoking with patients. The first video - the
wrong approach – showed a doctor bullying a patient into giving up
smoking, with the patient becoming agitated and upset during the
conversation. While the second video showed the same doctor
explaining to the patient in a calm and understanding manner how
important it is that she quit smoking, and describing different aids to
help her do this. 
Physiotherapist Stephanie Tarrant presented a hugely beneficial talk
on the causes and prevention of muscle injury in the dental practice.
The dental profession holds an 80% incidence report compared to
other health care groups. The factors that lead to muscle injury
include: prolonged repetitive forceful or awkward movements; poor
posture; ill-fitting chairs and equipment; and, a fast-paced workplace.
Stephanie gave a number of helpful tips to reduce the risk of muscle
injury. 
During the presentation, Stephanie highlighted the need for a survey
of current members to determine the extent of musculoskeletal injury
within the industry. She explained: “Unless we know where we are,
we can’t move forward, we can’t make things better.”
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CPD central
RÓISÍN TREACY and PAUL O’GRADY report from the Association’s Annual Conference in Kilkenny in
May where dentists had the chance to experience a wide range of CPD.
Earning stripes
After lunch, delegates were given the opportunity to earn more CPD
points during Stanley Malamed’s ‘Emergency medicine: back to
basics’ presentation. Healthcare providers have both a legal and moral
obligation in emergency management – they must keep the victim
alive until he or she either recovers, or help arrives to take over
management. Stanley explained that the dental team must have a
predetermined plan for managing medical emergencies, and this
team is made up of three members. The first member is the first
person on the scene of an emergency, their responsibility is to shout
for help, stay with the victim and perform basic life support if
necessary. The second member responds to the call for help and gets
the necessary equipment (defibrillator, etc.), while the third member
is everyone else on the dental team, and they are responsible for
calling emergency services. The presentation went on to include
advice on what to do in the case of seizures, asthma, allergies, and
chest pain. 
Paddy McCann’s address on mouth cancer was certainly not one for
the faint hearted. The picture-heavy presentation showed an array of
different oral cancer cysts and tumours, in the pre-operative,
operative, and post-operative stage. Paddy stressed the importance of
taking an extensive patient history when it comes to patients with oral
cancer, in order to determine how fit they will be for the journey, and
whether they have the support required to get them through it. 
Endurance specialist
High-achieving endurance athlete Gerry Duffy gave a highly
entertaining and motivating speech about his journey from a hum-
drum, unhappy lifestyle in his mid-twenties to achieving many goals
in his life. Interestingly, he noted that perhaps the single biggest
challenge he faced was not completing something as extreme as the
Deca Iron Man Challenge (which he won), but giving speeches. It has
taken him most of his life to get to the stage where he is not filled with
fear and dread ahead of a speech. It was only as recently as 2011 that
Gerry reached a point where he felt confident that he could deliver a
speech. 
Gerry described his seven key habits for success, which are: 1) give
yourself time to think; 2) improve your physical fitness; 3) surround
yourself with great people; 4) be enthusiastic; 5) be different in your
approach; 6) commit to continuous improvement; 7) constantly
check your mindset. His favourite saying is: “It’s not what happens to
you, it’s what you do about it.”
Orthodontics focus
There were two contrasting presentations on orthodontics on the
Saturday. The first was from Dr Michael Ormonde of the Kylemore
Clinic in Kilkenny who addressed the theme of “The changing face of
orthodontics”. He acknowledged that digital technology had brought
a lot to orthodontics but, he said, you need to know what to do with
it. Michael reviewed many of the techniques currently being offered
to general dental practitioners, pointing out their strengths and their
weaknesses, and cautioned that taking on an orthodontic case that
doesn’t work can be enormously stressful. “I have had referrals and
I’ve finished cases that prove that the dream that is being sold does
not always work.”
Dr Tif Qureshi, on the other hand, is a part-owner of the Inman
company. He addressed the topic ‘Truly minimally-invasive dentistry
for every dentist’. He stated that the golden rule for any dentist taking
on cosmetic work was “Do unto others as to yourself” and that
sometimes referral to a specialist orthodontist is the best treatment for
the patient. The big question, he said, is: should GDPs be doing
orthodontic work? The answer, he stated, is given by the answer to a
question that every dentist has to ask themselves: is it within your
capability? His view is that simple orthodontic work is well within the
scope of the GDP and that showing the correct planning and getting
the proper, informed patient consent will result in professional respect
for that work. The benefits he stated as: high patient acceptance;
appropriate and low-risk work; progressive smile design (which he
described as align, bleach, contour); de-radicalised preps; and far less
stress.
Quality in dentistry
Professor Martin Tickle of the University of Manchester addressed the
topic of quality in dentistry. Surprisingly, he revealed that quality in
dentistry has tended, up to now, to be equated with complex
restorative work. However, work is now underway to measure quality
at the micro (individual dentist); meso (practice); and, macro (policy)
levels. Improving quality, he said, requires shifting the performance of
the entire system. Therefore, intervention and implementation are
required. The acknowledged intervention methodology is: agree
goals; agree how goals are measured; identify changes needed to
achieve goals; test those changes; sustain and spread change.
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A special presentation was made
to Dr Barry Harrington on the
occasion of attending his fiftieth
IDA Annual Conference. Dr P.J.
Byrne gave the citation and
made the presentation.
Another presentation was made
to IDA staff member Mary
Graham as a gesture of thanks
for her great service for more
than twenty years as she
approaches retirement.

Professor David Whittaker was born in 1939
and brought up on the Lancashire side of
the Penines in England. At the age of 11, he
won a State scholarship to grammar
school and went on to study dentistry at
the University of Manchester. Why did he
choose dentistry? He had two cousins who
studied medicine and he feared he
wouldn’t ever be as good as either of them!
He always harboured a desire to be a
surgeon, so went on to train as a maxillo-
facial surgeon. While at an advanced stage of
training (he was by then a Senior Registrar)
and lecturing in the University of Manchester,
he was poached by Cardiff University who
were looking for something unusual – a
person to teach the surgical anatomy of
the head while also practicing as a
clinician. Importantly, this ensured that David
received a consultant’s contract while teaching, doing research and
doing two clinical sessions a week as a maxillo-facial surgeon.
Just before moving to Cardiff, a plane crashed into a petrol station in
Stockport, killing 75% of the people on board. He was asked to help
gather the dental records to allow the bodies to be identified. Very
shortly after that, the Dean of the Dental School in Cardiff rang and
asked if he had any experience of dental forensics as the police had a
body they could not identify. From that point on, he worked closely
with the pathologist Professor Bernard Knight and their work
culminated in their collaborations on the victims of Fred and Rosemary
West. 
Developing forensic techniques
Over the years, Professor Whittaker realised that most forensic dentists
were GDPs who worked off their own records. As the volume of
forensic work he was being asked to do increased, he made an
agreement with the University to channel the fees for that work into
the setting up of properly-equipped forensic dentistry laboratories, and
his title was amended to Professor of Oral Biology and Forensic
Dentistry. The laboratories allowed him and his now team of colleagues
to use electron microscopy and DNA to determine the gender of the
victim and their age at death. He further advanced understanding by
examining teeth of victims so that he could tell which type of filling
material had been used, and even which type of burr had been used
to drill the cavity.
Some of the cases he dealt with were terribly gruesome. Apart
from the victims of the Wests, he dealt with a road traffic
accident in Cornwall in which 12 people (three cars each
with four people, travelling together to a social function)
had been killed. They had all been decapitated by the
bucket of a JCB which had swung out from the low loader
truck on which it had been travelling at approximately 60
miles per hour. The cars had also been travelling at about
60 miles per hour in the opposite direction, and so the
impact of the collision was especially horrifying. He
collected all the parts and made all the necessary
identifications. Asked if the macabre nature of
his work ever upset him, he says
that he treated it as
science and trained
himself to become
emotionally detached. He
never talked about the work
outside of a work setting.
That allowed him to, as he
described it, “wash my hands and go home.”
The Hitler case
One day at work in the 1970s, his colleague Professor Knight came
over to his office. He had with him a copy, translated into English, of
the post mortem carried out by the Russians on the remains of Hitler.
It was, surprisingly, 30 pages in length; but exactly what happened to
the body was obscure. It became a lifelong interest for Professor
Whittaker and he has, over the years, put the various pieces of the story
of what happened to Hitler’s body together. While other scientists have
also worked on this story too, Professor Whittaker related it to the
Journal of the Irish Dental Association as follows.
It appears Hitler had a terror of having his body put on display
somewhere after the war. Therefore, he gave instructions that his body
(and that of Eva Braun) be burnt after he killed himself. This was done
shortly before the Russians reached his bunker in Berlin in April 1945.
Despite the remains being charred, the Russians took them to Moscow
after a post mortem had been carried out. The post mortem was given
to Professor Whittaker because the only significant remains were the
upper and lower jaws. The post mortem, which appeared to have been
smuggled out of Russia by a former Russian soldier, contained
photographs and medical and dental descriptions of the upper and
lower jaws. The question was whether the post mortem was genuine. 
Professor Whittaker set about the long task of seeing if he could
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Searching for the tooth
One of the world’s leading forensic dentists, Professor David Whittaker, was in Kilkenny for the
Association’s Annual Conference. He spoke to PAUL O’GRADY about his work, and especially 
about his long-established interest in identifying Hitler’s remains.
EVIDENCE
establish its veracity. He got in touch with a colleague in the USA, Dr
Ryder Sognaes, who had contacts with the CIA. They asked: does the
Pentagon have any material that might help? It appeared that they did.
First of all, they had full head X-rays of Hitler from a hospital in
Germany that had been taken just after the bomb went off in the
Wolf’s Lair, which Hitler had been lucky to survive on July 20, 1944. 
Additionally, while Hitler had been careful to dispose of his medical and
dental records in the weeks prior to his death, his dentist, Dr Hugo
Blaschke, had trained in Pennsylvania in the USA. He described Hitler’s
dental treatment in detail when interviewed by the US Secret Service
after the war. His dental nurse, Frau Hauserman, also described her
memories of the treatment of Hitler to the Americans. So while there
were no formal records, there were two independent accounts of
Hitler’s dental treatment and full head X-rays from 1944.
Professor Whittaker succeeded in getting the X-rays and the
descriptions so that he could compile charts and diagrams which
reflected the state of Hitler’s dentition. He then compared those results
with the results of the port mortem carried out by the Russians. The
outcome, he said, was that if he was asked to present his findings and
his professional opinion in a British Court of Law, he believes the
Coroner would identify the body as that of Hitler.
There is an interesting postscript. The BBC asked him if he would
accompany them to Russia where they were hoping to be shown the
actual remains. He agreed, but the travel was cancelled when the
Russians, who had previously been co-operative, had very suddenly
decided that the trip would not go ahead. Although there has been
some speculation that the remains have been destroyed, Professor
Whittaker believes that it was a change of those in power in Moscow
around that time that caused the change of heart.
So what does he believe has happened to Hitler’s remains? He says that
it appears that after the post mortem, Hitler’s remains (and those of Eva
Braun and the Himmler family) were taken to ground outside Moscow
and buried. That ground was identified in documents held in KGB
headquarters and around the time of the fall of the USSR in 1991, the
KGB went to the ground, which apparently now was a car park, and
dug up the remains. “As far as we know,” says Professor Whittaker,
“they still have them.”
What’s so special about teeth?
In his address to the Conference, Professor Whittaker said that for a
forensic scientist, teeth are special for three reasons: they are unique
to the individual; they survive death; and, they are biologically inert,
i.e., whatever you put in them tends to stay there!
If dental records exist, then you probably already know the identity
of the body/victim – therefore most work for forensic dentists is in a
scenario where dental records do not exist. Teeth then are very
helpful in determining gender, and age at time of death. Dental
forensics can also be very useful when bite marks are left on victims. 
General dental practitioners play a crucial role in dental forensics by
keeping dental records. Professor Whittaker urged all dentists to pay
close attention to their record-keeping. When asked to manage the
identification of bodies of British victims of the tsunami in 2004 in
Thailand and elsewhere, he observed fantastic dentistry, but not
always fantastic record keeping. 
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David Whittaker (above left) is
certain the remains found were
those of Adolf Hitler (left).
The Stockport plane crash
(above right) in 1967 killed
75% of passengers. 

Introduction
Anticoagulation therapy is indicated in
several conditions to prevent, treat, or
reduce the recurrence risk of
thromboembolism. Included in these
conditions are: deep vein thrombosis (DVT);
pulmonary embolism (PE); atrial fibrillation;
prosthetic and rheumatic heart valves;
myocardial infarction; transient ischaemic
attacks; and, stroke. Over the last 40 years,
the coumarin-derivative, vitamin K
antagonist, warfarin has been the oral
anticoagulant of choice and has been
considered the mainstay of treatment.
Indeed, it has, along with other vitamin K
antagonists, been the most widely-available,
orally-administered anticoagulant.1,2
However, like all medicines, warfarin is not
without its disadvantages. Its use is limited
by a narrow therapeutic index and complex
pharmacodynamics, necessitating regular
monitoring and dose adjustments. In
addition, it has multiple drug and dietary
interactions. These disadvantages created an
impetus for the development of novel oral
anticoagulants with a wider therapeutic
index, less interactions, and a predictable
level of anticoagulation at a specific dose.
Recently, two new oral anticoagulants,
dabigatran etexilate (a direct thrombin
inhibitor) and rivaroxiban (a factor Xa
inhibitor) have been approved for use in
North America and Europe. In Europe, both
dabigatran and rivaroxiban are licensed for
short-term primary prevention of venous
thromboembolic events in adult patients
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New oral anticoagulants and their
implications for dental patients
Anticoagulation therapy is used in several conditions to prevent or
treat thromboembolism. Over the last 40 years, warfarin has been
the oral anticoagulant of choice and has been considered the
mainstay of treatment. However, its use is limited by a narrow
therapeutic index and complex pharmacodynamics, necessitating
regular monitoring and dose adjustments.
Recently, two new oral anticoagulants - dabigatran etexilate (a
direct thrombin inhibitor) and rivaroxiban (a factor Xa inhibitor) -
have been approved for use in North America and Europe. Unlike
warfarin, dabigatran and rivaroxiban are relatively small molecules
that work as anticoagulants by targeting specific single steps of the
coagulation cascade. Their advantages, relative to warfarin, include:
predictable pharmacokinetics; limited food and drug interactions;
rapid onset of action; and, short half-life. They require no
monitoring. However, they lack a specific reversal agent. 
The number of patients taking dabigatran and rivaroxaban is
increasing. Therefore, it is inevitable that dentists will be required
to perform invasive procedures on this cohort of patients. This
paper outlines the various properties of the new oral anticoagulants
and the most recent guidelines regarding the management of these
dental patients taking these medications.
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who have undergone elective total hip or knee replacement surgery,
while dabigatran is also licensed for prevention of stroke and systemic
embolism in adult patients with non-valvular atrial fibrillation, plus
one or more additional risk factors. Dabigatran is contra-indicated in
patients with a prosthetic heart valve requiring anticoagulant
treatment.3 Unlike warfarin, dabigatran and rivaroxiban are relatively
small molecules that work as anticoagulants by targeting specific
single steps of the coagulation cascade.4 In addition, they are reported
to have fewer drug-drug interactions, no significant food interactions,
and provide predictable anticoagulation at a specific dose, without
the need for regular laboratory monitoring and alterations of dose.5,6,7
The pharmacologic properties of dabigatran, rivaroxaban, and
warfarin are outlined in Table 1. 
As the number of patients taking dabigatran and rivaroxaban
increases, it is inevitable that dentists will encounter them in the near
future. It is therefore incumbent on all of us to become familiar with
these drugs, their indications and method of action, and in particular
the management of those patients requiring invasive dental
procedures, so that these patients are managed in a safe manner. This
present paper outlines the various properties of the new oral
anticoagulants and the most recent guidelines regarding the
management of these patients in dental practice.
Materials and methods
Dabigatran (Pradaxa®; Boehringer Ingelheim)
In October 2010, the Food and Drug Administration (FDA), USA, first
approved the use of dabigatran etexilate to reduce the stroke and
systemic embolisation risk in patients with non-valvular atrial
fibrillation. It is now also used, in the EU and Canada, for
thromboembolic prophylaxis in patients who have recently
undergone a total hip or knee replacement.8,9 Recent studies have
shown that dabigatran, given at a fixed dose (owing to predictable
pharmacokinetics) does not require monitoring and is as effective as
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TABLE 1: Indications for and pharmacology of oral anticoagulants.
Indications
Dose and regimen
Site(s) of action
Oral bioavailability
Time to peak plasma
concentration (Tmax)
Half-life (T½)
Metabolism
Renal elimination
Need for monitoring
Warfarin
DVT, PE
Prevention of thrombosis in AF
Prevention of recurrent MI
MHV
Titrated according to INR
Once daily
Factors II, VII, IX, and X
Proteins C and S
~100%
2-8 hours
20-60 hours
Primarily CYP2C9 (liver)
90-100%
Regular INR
Dabigatran
Prevention of CVA in AF
VTE prophylaxis in elective THR, TKR
Range: 110-150mg BD for AF; 220mg daily
for THR/TKR
Thrombin
3-7%
2-4 hours
12-17 hours
Up to 28 hours in severe renal impairment 
Esterase catalyzed hydrolysis in plasma/liver
80-85%
None
Rivaroxaban
VTE prophylaxis in elective THR, TKR
10mg once daily
Factor Xa
80-100%
2.5-4 hours
5-13 hours
Liver: CYP3A4, CYP3A5, CYP2J2
66%
None
Abbreviations
AF atrial fibrillation
CVA cerebrovascular accident 
CYP cytochrome P 
DVT deep venous thrombosis
INR international normalised ratio
MHV mechanical heart valve 
MI myocardial infarction
PE pulmonary embolus
THR total hip replacement
TKR total knee replacement
warfarin in preventing embolic events in patients with atrial
fibrillation. The Randomised Evaluation of Long-Term Anticoagulation
Therapy (RE-LY) trial demonstrated that, compared with warfarin,
dabigatran 150mg twice daily is more effective at preventing stroke
and systemic embolisation with a similar risk of major bleeding,
whereas dabigatran 110mg twice daily is associated with a lower risk
of major bleeding and a similar rate of stroke and systemic
embolisation.10 It has also been shown to be equivalent to warfarin in
the prevention and management of recurrent venous thrombo-
embolism (VTE) and PE.11 However, significant concerns regarding the
lack of a reversal agent, and difficulty in precisely monitoring its anti-
coagulant effect remain. 
Mechanism of action and pharmacology
It is a specific, reversible, direct thrombin inhibitor that, unlike
warfarin, inhibits both free and fibrin-bound thrombin.12 It binds to
the active site on the thrombin molecule (Factor II a) so that
fibrinogen cannot be converted into fibrin.5
Dabigatran etexilate is a pro-drug which, following oral administration
is converted to its active form, dabigatran. When administered orally,
the bioavailability is approximately 3-7%. It is rapidly absorbed and is
metabolised by the liver. It has a rapid onset of action with a peak
plasma concentration at 0.5-4 hours.13,14 When administered twice
daily, a steady state plasma concentration is reached within two to
three days.13 The half-life elimination is 12-14 hours in healthy
patients, 14-17 hours in the elderly, and up to 27 hours in patients
with severe renal impairment (i.e., creatinine clearance <15-30
ml/min). There is no evidence for an alteration in pharmacodynamics
in patients with moderate hepatic impairment (Child-Pugh B).14
Laboratory testing/monitoring
Unlike warfarin, routine monitoring of the anticoagulant effect of
dabigatran is not required. However, certain situations such as
emergency surgery, intra-cranial/cerebral bleeding, and overdose may
require assessment of anticoagulation. The thrombin clotting time
(TT), and ecarin clotting time (ECT) are reported to be the most
sensitive tests for quantifying the anticoagulant effects of dabigatran.
However, the ECT test is not widely available. The activated partial
thromboplastin time (aPTT), whilst widely available, is less sensitive
particularly at higher dabigatran doses.15,16 Most dentists are familiar
with the prothrombin time (PT), often expressed as the international
normalised ratio (INR). However, this test is less sensitive than others
and cannot be relied upon to determine the anticoagulant effect of
dabigatran.
Adverse reactions
The RE-LY trial reported that more than 15% of patients experienced
gastritis type symptoms.10 Minor bleeding events were reported in 8-
33%, and major bleeding in less than 6%. In addition, it reported
drug hypersensitivity (including urticaria, rash, and pruritus), allergic
edema, anaphylactic reaction, and anaphylactic shock in less than
0.1% of patients.
Reversal agent
Currently, there is no reversal agent for the dabigatran. However,
owing to its short half-life, discontinuation of the drug may be
sufficient to resolve minor haemorrhage, with the exception of
patients with renal impairment. For more persistent or major
bleeding, supportive measures such as pressure, vessel ligation, fluid
replacement, and transfusion of blood products can be employed.
Recombinant factor VII (rFVIIa), prothrombin complex concentrates,
and/or haemodialysis may also be considered.15
Drug interactions
Unlike Warfarin, it appears that dabigatran has few clinically significant
drug and food interactions. Ketoconazole, verapamil, and amiodarone
may increase its anticoagulant effect, whilst rifampicin may decrease its
effect. The risk of bleeding whilst on dabigatran may be increased by
concomitant use of other anticoagulants, antiplatelets, and
salicylates.12 Stangier reported that the concomitant use of the non-
steroidal anti-inflammatory drug (NSAID), diclofenac sodium, and
dabigatran did not produce a significant interaction.17 Nevertheless,
given that non-cox-selective NSAIDs inhibit platelet aggregation and
are associated with gastro-intestinal bleeding and peptic ulcer disease,
it may be prudent to avoid their use in patients taking dabigatran.
Paracetamol and opioid analgesics are suitable alternatives.18
Specific dental considerations
Unfortunately, to date, there are no clinical trials supporting specific
measures in the event of haemorrhage in dental patients taking
dabigatran. The most current information suggests that patients
taking dabigatran can undergo invasive dental procedures without
alteration of dose. As is the case with all patients, irrespective of
coagulation status, local haemostatic measures (absorbable gelatin or
oxidized cellulose pellets, sutures, gauze soaked in 5% tranexamic
acid, pressure) should be employed in the event of bleeding. Owing
to the risk of thromboembolism, dabigatran should never be
discontinued without prior consultation with the treating physician.
Firriolo and Hupp, studied data from reports on post-extraction
bleeding in patients receiving low molecular weight heparin
(LMWH).5,19,20 In addition, they looked at the recommendations of
van Ryn et al regarding the discontinuation of dabigatran before
elective general surgery, and concluded that there should not be a
significant risk for serious bleeding after dental treatment, including
most uncomplicated dental extractions, in patients with normal renal
function and without other risk factors for bleeding.15 However, they
continue to say that a temporary cessation of dabigatran may be
required in patients requiring major oral/maxillofacial surgery. If this
is the case, dabigatran should be discontinued (following
consultation with the patients physician) at least 24 hours (or longer
in renal impairment) before elective surgery. In addition,
consideration should be given to performing a TT or aPTT six to 12
hours prior to surgery, which, if normal, indicates that the
coagulation is normal and that the anticoagulant effect of dabigatran
has resolved.5,15,21
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Dabigatran should only be recommenced post-operatively once a
stable clot has formed, thereby minimising the risk of bleeding. This
is particularly important with dabigatran, and indeed rivaroxaban, as
unlike warfarin, their onset of effect is predictable and rapid. 
If discontinuation of anticoagulation is not considered safe, and
extensive oral surgery is required, peri-operative bridging
anticoagulation with an appropriate dose of subcutaneous LMWH or
unfractionated heparin is recommended.
The RE-LY trial involving over 18,000 patients, looked at (amongst
other things) the levels of bleeding in dabigatran versus warfarin.10
Whilst the level of both major and minor bleeding was lower amongst
the cohort taking dabigatran, no significant statistical significance was
found. 
A secondary analysis of the RE-LY trial showed that 4,591 patients had
undergone at least one invasive procedure, with cessation of
anticoagulation pre-operatively.22 Interestingly, 10% (460) of these
procedures were dental, which was the second most common type of
surgery. Dabigatran was discontinued 24-72 hours (average 49 hours)
or more pre-operatively, based on renal function and bleeding risk,
and warfarin was discontinued an average of 114 hours pre-
operatively. The analysis demonstrated similar rates of perioperative
bleeding for both dabigatran and warfarin. More specifically, the
incidences of major perioperative bleeding were 3.1% with
dabigatran 110mg, 5.1% with dabigatran 150mg, and 4.6% with
warfarin.44 However, despite the fact that approximately 460 dental
procedures were included in this study, it is difficult to find specific
perioperative measures or guidelines as information regarding the
duration and type of procedure are limited. Therefore, it is important
to highlight that it is difficult to recommend this study as a guide for
the management of patients requiring dental procedures.
Romond et al., in a recent paper, describe the successful management
of a patient taking dabigatran who required multiple extractions.23 As
per the recommendations of van Ryn et al., they held the patients’
dabigatran 24 hours prior to the procedure, which involved eight
extractions, alveoloplasty, and tuberosity reduction.15 They reported
no prolonged post-operative bleeding. Interestingly, they also stated
that had the patient required only one to three extractions,
consideration would have been given to not stopping the patients’
dabigatran. Weitz et al., also suggest that dabigatran does not need
to be stopped in cases where the bleeding risk is low and cites dental
extractions as an example.24
Rivaroxaban (Xarelto®; Bayer)
Rivaroxaban is an orally-administered, selective, reversible, direct
inhibitor of activated factor X (factor Xa), and is currently indicated for
prophylaxis of venous thromboembolism (VTE) in adults after hip or
knee replacement surgery. A number of studies have demonstrated
that rivaroxaban can reduce VTE and all cause mortality in these
patients.25,26,27
The ROCKET-AF trial investigated the effectiveness of rivaroxaban,
relative to warfarin, in the reduction of ischaemic stroke or systemic
embolism in patients with atrial fibrillation.28 However, the FDA has
yet to approve its use in the setting of atrial fibrillation, based on a
perceived lack of evidence.29
Mechanism of action and pharmacology
Rivaroxaban is an oxazolidinone derivative that inhibits factor Xa and
interrupts both the extrinsic and intrinsic coagulation pathways,
thereby inhibiting thrombin formation.12
It is rapidly absorbed and has a rapid onset of action of two and a half
to four hours. The half-life is five to nine hours in healthy adults, and
11-13 in the elderly (due to decreased total and renal clearance).30
Oral bioavailability is 80-100% and the duration of effect is 10-18
hours.4 It is excreted in the urine (66%) and faeces (28%).31
Laboratory testing/monitoring
Like dabigatran, routine monitoring of rivaroxaban is not required.
However, in an emergency situation, measurement of the level of
anticoagulation may be indicated. Anti-factor Xa assay is reportedly
the most accurate measurement of the anti-coagulant effect of
rivaroxaban (as well as LMWHs).21 In addition, some authors suggest
that aPTT and PT (with rivaroxaban specific calibration) may also be
used.32,33 The activated aPTT and HepTest® are prolonged dose-
dependently; however, they are not recommended to assess the
pharmacodynamic effect of rivaroxaban.30
Adverse reactions
Approximately 1-10% of patients taking rivaroxaban experience an
adverse reaction.34 Major bleeding occurs in 1-2%, and minor
bleeding in 4-7%. Nausea occurs in 1% of patients.
Reversal agent
Unlike warfarin, there is no specific agent to reverse the anti-coagulant
effect of rivaroxaban. However, owing to its short duration of action,
discontinuation of the drug should be sufficient to arrest persistent
minor haemorrhage. Severe or life-threatening haemorrhage may
require the use of blood product transfusion, recombinant Factor VIIa,
or prothrombin complex concentrate (PCC).35,36
Drug interactions
Two thirds of rivaroxaban is metabolised by the Cytochrome P450
(CYP) system, especially CYP3A4. In addition, rivaroxaban is also a
substrate of P-gp transporters.5 Therefore, the concomitant use of
rivaroxaban with inhibitors or inducers of CYP3A4 should be
avoided.35,37 CYP3A4 inhibitors, which can increase the serum
concentration of rivaroxaban and therefore the risk of bleeding,
include erythromycin, ketoconazole, and amiodarone. Clarithromycin
is considered a strong CYP 3A4 inhibitor, and a moderate P-gp
inhibitor. However, the increase in peak serum concentration of
rivaroxaban when administered with a twice-daily dose of
Clarithromycin 500mg was found to be of no clinical relevance in one
study.38 Conversely, CYP3A4 inducers such as phenytoin, rifampicin
and St Johns wort may increase the metabolism of rivaroxaban,
thereby decreasing the level of anticoagulation. Non-steroidal and
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opioid analgesics should be used with caution in patients taking
rivaroxaban.5
Specific dental considerations
Similar to dabigatran, there are currently no clinical trials in the
literature offering specific recommendations for the management of
dental patients taking rivaroxaban. 
Turpie et al., suggest that interruption of rivaroxaban is not required
for simple dental extractions.39 The guidelines given above in relation
to dabigatran are also applicable to rivaroxaban. Therefore, it is not
necessary to discontinue rivaroxaban for uncomplicated extractions
and other similar invasive dental procedures in patients with normal
renal function. Local haemostatic measures, as described previously,
should be employed when necessary. For patients undergoing elective
oral/maxillofacial surgery, where the bleeding risk is significant,
rivaroxaban should be discontinued (only after consultation with the
patients physician) for at least 24 hours before surgery. A longer time
period will be required in patients with renal dysfunction.4,40
Warfarin
The guidelines for management of dental patients taking warfarin,
have previously been well described in the literature.41-44 However, for
completeness, a summary of the management of dental patients
taking warfarin is included here. Warfarin inhibits the enzyme vitamin
K epoxide reductase, therefore inhibiting the formation of vitamin K-
dependent coagulation factors II, VII, IX, and X, and proteins C and S.
The maximum anticoagulant effect of warfarin takes 48 to 72 hours to
develop, with an estimated duration of action of two to five days and
a reported half-life of two and a half days. It is important to stress that,
owing to the risk of a potentially fatal thromboembolism, cessation of
warfarin therapy prior to dental treatment is not recommended.
Instead, an INR should be taken 24 to 48 hours pre-operatively to
establish the degree of anticoagulation. In general, it is safe to proceed
with an invasive dental procedure (including administration of local
anaesthesia, periodontal or endodontic surgery, and routine/surgical
extractions) if the INR is less than or equal to 3.5. Local haemostatic
measures should be employed routinely. If the INR is greater than 3.5,
the dentist should liaise with the treating physician in order to safely
reduce the warfarin dosage. Due to warfarin’s long half-life, a period
of three to five days is required for a reduction in the level of
anticoagulation, as reflected in a reduced INR. An INR again needs to
be taken 24 to 48 hours prior to the procedure to ensure that it is less
than or equal to 3.5. Finally, all dentists should be cognisant of the
potential interaction between warfarin and other drugs commonly
used in dentistry, including azole antifungals, macrolide antibiotics,
and NSAIDs.
Discussion
Oral vitamin K antagonists have, for many years, been the
mainstay of management for VTE treatment and prevention.
Despite their widespread use, they are not without problem. They
require regular monitoring and dose titration. In addition, they
have multiple food and drug interactions. Despite this, the
availability of an antidote, specifically Vitamin K, is somewhat
reassuring. In the event of a significant or life-threatening bleed,
prothrombin complex concentrate may also be used. Recently, the
search for a better alternative to Vitamin K antagonists has resulted
in the production of two new drugs, namely dabigatran etexilate
and rivaroxaban. Their advantages, relative to warfarin, include
predictable pharmacokinetics, limited food and drug interactions,
rapid onset of action, and short half-life. They also require no
regular monitoring or dose titration. A Cochrane review of 14
studies, incorporating 27,746 patients, comparing direct thrombin
inhibitors to vitamin K antagonists and LMWH showed no
statistically significant difference in the risk of bleeding.45 However,
the lack of a specific reversal agent remains a concern.
The RE-LY trial, which was referred to in the above section on
dabigatran, looked at (amongst other things) the levels of bleeding
in dabigatran versus warfarin.10 Whilst the level of both major and
minor bleeding was lower amongst the cohort taking dabigatran,
no noteable statistical significance was found. However, significant
concerns have since been raised regarding severe bleeding events
(in patients whose anticoagulation was not stopped) and their
management (or lack thereof) in patients taking dabigatran.46-47
To our knowledge, there are no randomised controlled trials
looking at the peri-operative management of bleeding in dental
patients taking dabigatran or rivaroxaban. Romond et al. describe
the successful management of a patient taking dabigatran who
underwent multiple extractions.22
Van Diermen et al. in an extensive literature review and summary
of papers dealing with the management of dental patients
receiving oral anti-thrombotic medication (including the novel oral
anticoagulants) proposed an updated clinical practice guideline for
dentists.48 They concluded that the evidence does not support
cessation of oral antithrombotic medication for simple dental
procedures. More specifically, they recommend that novel oral
anticoagulant treatment (including dabigatran and rivaroxaban)
should not be interrupted to facilitate simple dental procedures
(e.g., up to three dental extractions, up to three dental implants,
and periodontal surgery).
Most current guidelines are largely based on expert opinion and
the pharmacologic  propert ies  of  the new ora l
anticoagulants.5,12,15,18,22
Current available information suggests that the risk of bleeding in
patients undergoing invasive dental procedures (for example,
extractions) is low, provided that local haemostatic measures
(suturing, gelatin sponge, gauze soaked 5% tranexamic acid,
tranexamic acid mouth rinse) are used and the patient has normal
renal function. Indeed, the risk seems to be analogous to patients
taking warfarin and with an INR of between two and three. For
patients requiring multiple extractions, or oral/maxillofacial
procedures, consideration must be given to discontinuation of
dabigatran/rivaroxaban, with the duration determined by renal
function and bleeding risk.15 However, as stated previously,
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dentists should not discontinue oral anti-coagulants without prior
consultation with the patients’ physician. If discontinuation is not
feasible, due to the risk of VTE, bridging with LMWH or intra-
venous unfractionated heparin, as per the ACCP guidelines for
patients taking vitamin K antagonists, is required.49
It is also important to be cognisant of the potential drug
interactions between rivaroxaban/dabigatran and the drugs
commonly used in dentistry, as outlined previously. 
Conclusion
As the number of patients taking dabigatran and rivaroxaban
increases, it is inevitable that dentists will encounter them in the near
future. It is therefore incumbent on all of us to become familiar with
these drugs, their indications and method of action, and, in particular,
the management of those patients requiring invasive dental
procedures. As our experience with these medicines increases, so will
our understanding of appropriate management measures. Currently,
no specific protocols are available and further observational studies
and randomised controlled trial are required to properly define
management guidelines. 
Summary of management of dental patients taking
dabigatran or rivaroxaban
4 Based on current information, in patients with normal renal
function taking dabigatran or rivaroxaban, invasive dental
procedures can be carried out without interruption of the
medication.
4 All procedures should be performed as late as possible after the
most recent dose.
4 Local haemostatic measures should be used routinely in these
patients.
4 Patients requiring oral/maxillofacial surgery may need
discontinuation of oral anticoagulants for at least 24 hours
preoperatively, but always in consultation with treating physician.
4 If stopped pre-operatively, dabigatran and rivaroxaban should
only be re-commenced when a stable clot has formed (typically
24-48 hours post-operatively).
4 If post-operative bleeding occurs, stop the oral anticoagulant,
employ local haemostatic measures, and contact the patient's
physician.
4 For patients taking dabigatran, transfusion with packed red cells
(PRC) or fresh frozen plasma (FFP) should be considered, plus
haemodialysis +/- rFVIIa if required.
4 For patients taking rivaroxaban, transfuse with PRC, or FFP, and, if
available, give prothrombin complex concentrate or rFVIIa.
4 NSAIDs and salicylates should be used with caution with
dabigatran. Paracetamol and opioids are acceptable alternatives.
4 NSAIDS, salicylates, macrolide antibiotics (especially erythromycin
and clarithromycin), fluconazole, and opioids should be used with
caution with rivaroxaban.
4 Avoid ketoconazole, itraconazole, and voriconazole with
rivaroxaban.
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Oral health behaviours amongst
homeless people attending
rehabilitation services in Ireland
Statement of the problem: Research on oral health behaviours and
dental care service uptake of drug users and those in recovery
remains scant.
Purpose of the study: The research aimed to explore and describe
perspectives of drug users on their oral health behaviours,
awareness of oral health complications caused by alcohol, cigarette
and drug use, dental service uptake and opinions on improved
dental service for active and recovering addicts.
Materials and methods: Two focus groups with a purposeful sample
of participants (n=15) were conducted in two treatment and
rehabilitation settings. The semi-structured guide consisted of open
questioning relating to dental access and uptake, oral health,
awareness of oral cancers, nutrition and substance consumption on
oral health, and opinions around optimum oral health and dental
service provision for active drug users and those in recovery.
Thematic analysis of narratives was conducted.
Results: Participants described barriers to access and uptake, poor
levels of preventative dental care, DIY dentistry in the event of
dental emergencies, substance use to self-medicate for dental pain,
mixed awareness of the effects of sugary products and substance
use on oral health and cancers, and emphasised the importance of
preventative dental care and dental aesthetics when in recovery.
Conclusions: Findings illustrate a profile of oral health behaviours
in Irish drug users, with information useful for private and public
practice, and in the further development of street, community and
treatment setting oral health interventions. 
Keywords
Oral health; dental health; addiction; dependency; qualitative.
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Introduction
Oral health forms an integral part of an individual’s physical health
and well being.1 Abuse of tobacco and alcohol products, combined
with drugs, worsens oral disease and contributes to oral
complications. Consumption of licit and illicit drugs has been
recorded amongst active drug users for dental pain management.2-7
Research on oral health needs and health care access among active
drug users and those in recovery remains scant, with studies confined
to the reporting of prevalence of oral cancers, brushing habits,
snacking, and recent visits to a dentist.7-13 Poor oral health among
users of illicit drugs is exacerbated by associated lifestyle factors in
terms of personal hygiene, lack of tooth brushing, smoking, irregular
eating patterns, consumption of sugary products, irregular dental
visits, and chronic malnutrition.4-6,8,10,12,17-19 It also results from direct
physiologic, drug-related effects, such as reduced salivary function.14-
16 Social and behavioural factors relating to socio-economic status, oral
hygiene, and childhood dental visits further complicate oral health
status.20 Concerns around dental appearance, missing, broken or
loose teeth, dental erosion, caries, and bruxism have been reported
amongst injecting drug users.7,14-16,21-,23
Despite the association between illicit drug use, and particularly
injecting drug use of opiates, low levels of users accessing oral health
services have been reported.13,24-25 Research underscores general low
uptake of preventative care services among injecting drug users, given
the high rates of associated complications26-29 and the need for
outreach and outpatient primary care services.30,31 Improved dental
and oral health is contributory to physical and psychological well
being within the recovery continuum, with poor dentition, related
lowered self-esteem, and poor uptake of oral health services
associated with poor treatment outcomes.2,21,23 Successful oral health
promotion activities situated in rehabilitation settings offer promise in
the facilitation of health behaviour change.9,32-34 Research has shown
that methadone maintenance treatment clients report increased rates
of health-care seeking behaviours.13
In 2006 in Ireland, the estimated national prevalence of opiate users
was between 18,136 and 23,576 (with a point estimate of 20,790).35
A total of 11,807 opiate users aged 15-64 years were known to
services in Ireland, with an estimated 8,983 users not known to the
services.35 Current national data systems report that opiates (mainly
heroin) were the most common problem drugs reported for those in
treatment.36 Opiate users in Ireland are characteristically aged
between 25 and 34 years, male, early school leavers, and
unemployed.36,37 Meanwhile, opiate use among Irish females is on the
increase since 2001.36 The predominant mode of opiate use in Ireland
is inhalation, closely followed by injecting and oral use.37 Opiate
dependence treatment uptake, in the form of methadone
maintenance treatment, is also increasing, with 11,538 cases treated
in 2007.36,37 Polysubstance use (alcohol, cannabis, benzodiazepines,
and cocaine) amongst users is common.36,37
To date, no research on the oral health of recovering opiate drug users
in Ireland has been conducted. The aim of this study was: to explore
and describe the perspectives of stabilised drug and alcohol users on
their oral health behaviours; awareness of oral health complications
caused by alcohol, cigarette and drug use; dental service uptake; and,
opinions on improved dental service for active and recovering addicts. 
Materials and methods
According to Neale et al.,38 exploratory or inductive research is based
on the description of ‘bottom up’ local, personal, or subjective
experiences of participants within the drugs field. A qualitative
methodology in the form of focus groups (n=2) was selected in order
to explore and investigate participants’ perspectives of oral health
awareness and behaviours, as well as their uptake and experiences of
access to dental services. A purposeful sample of participants (n=15)
willing to partake in the study were recruited from two detoxification,
treatment and rehabilitation services for homeless men and women.
Ethical approval for the study was granted by the Waterford Institute
of Technology Ethics Committee. Participants were provided with
information regarding the research aim, confidentiality assurances,
written and verbal consent, audio recording of the focus group(s), and
the right to withdraw from the focus group(s) at any stage. This
information was repeated by author two (EH), prior to
commencement. Each participant provided written and verbal
consent to partake, and all were provided with toothbrushes,
toothpaste, and dental floss (courtesy of Colgate, Dental Medical
Ireland (DMI), and Sensodyne). The semi-structured guide was
developed in consultation with the extant literature, the treatment
centre co-ordinators, and with the expertise of the second author (EH)
- a dental nurse. The semi-structured guide consisted of open
questioning relating to dental access and uptake; oral health;
awareness of oral cancers, nutrition and substance consumption on
oral health; and opinions around optimum oral health and dental
service provision for active drug users and those in recovery.
Questioning was kept neutral by actively inviting all participants to
share their opinions, in a non-judgmental manner so as to reduce bias
and optimise on accurate data retrieval. Focus group narratives were
transcribed, with the resultant combined text analysed thematically39
using NVivo 8, a qualitative text analysis software package. The text
data set was read and reread several times by both authors, in order
to identify and code the concepts found in the data, organise the
concepts, explain any data outliers, and to develop the final thematic
presentation of findings. 
Results
Participant ages ranged from 20 years to 56 years, with six
participants engaging in detoxification and nine participants currently
in rehabilitation. Three participants were engaging in methadone
maintenance treatment. 
THEME ONE: Access to and uptake of dental care
Roughly half of participants described themselves as routine dentist
attenders during childhood. Two participants reported that their
dental visits were confined to dental cleaning and for the extraction of
blackened teeth. 
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“I was only at the dentist three times in my whole life. Two of
those times were for a clean and polish.” 
Participant two, male, age 31 years.
Some participants described ‘symptomatic attendance’, by only
attending the dentist when experiencing toothache or when
necessitating dental extraction, with the majority observing how poor
personal dental care was exacerbated by substance abuse and
dependence in the past. 
“I was never one to mind oral hygiene.” 
Participant one, male, age 40 years.
“I didn’t really have a problem with ‘em, I’d only go if they
were sore.” 
Participant three, male, age 26 years.
“I’d no problems with me teeth. I’d only go to the dentist if I
needed an extraction.” 
Participant six, male, age 48 years.
Barriers to dentist visits were described as relating to lack of medical
card, lack of money, and presence of a continued substance
dependency problem. Current rates of dentist attendance ranged
from zero to two times in the past twelve months, with participants
describing their last previous routine screening, ranging between last
week and five years previous. Some comments were made around fear
of needles and use of rubber gloves in the dental surgery, and that this
deterred participants from attending for routine check-ups. Some
negative observations were made around medical card dentists. 
“I don’t like people sticking needles in me and the rubber
gloves are a funny taste in my mouth.” 
Participant seven, male, age 40 years.
“I’m afraid of the dentist, the needles scare me. I use needles,
but I don’t like those big needles you stick in your gums.” 
Participant 11, male, age 46 years.
Many comments were made around the importance of access to
dental care when in recovery, having a relationship with your dentist,
and the presence of a dental practice located onsite in treatment and
rehabilitation settings. 
“Yes most places want medical cards and here people are only
starting to get out of their addiction, and the teeth start to
matter and it would be very good if they could have it here.” 
Participant one, male, age 40 years.
“I think it would be a good idea having one here, to
encourage people to take care of their teeth.” 
Participant 13, female, age 39 years.
THEME TWO: Dental care
Levels of dental care in terms of brushing and flossing teeth were
described by most participants as neglectful in the past, with some
participants never brushing or flossing their teeth when in active
addiction. Some comments were made around use of toothbrushes to
attempt to knock off plaque, and the use of alcohol as mouthwash.
Frequency of brushing and flossing when in the treatment and
rehabilitation service setting had greatly improved, and ranged from
once to four times a day. No participants reported flossing their teeth,
either in the past or currently, with some participants reporting use of
toothpicks instead. Comments were made around bleeding gums
when attempting to insert toothpicks between teeth. 
When questioned around the occurrence of oral health issues or
dental emergency, some participants described the immediate
making of appointments at their dentist, with others reporting
delaying dental visits by the administration of toothpaste into the
dental cavity to reduce pain, the self-medication for dental pain with
painkillers (i.e., Nurofen), and the consumption of excessive levels of
alcohol, prescribed and illicit drugs to escape the pain. Two
participants without medical cards described doing nothing.
“I’d wait until the last minute. I’d be in agony and I’d use that
as an excuse to get mad out of it, because it would take the
pain away for a while.” 
Participant five, male, age 26 years.
“Depends on how bad it is. I go to a doctor and if he says go
to a dentist, I’ll go. But I go to the doctor first for painkillers. I
don’t like dentists.” 
Participant seven, male, age 40 years.
When probed around DIY dentistry in the event of a dental crisis,
some participants described scraping tooth stains and plaque from
their teeth with sewing needles and toothpicks, and attempts to
extract teeth with pliers, or by tying the affected tooth to a closing
door. 
“I did it once with a door. I scrape them sometimes with a
sewing needle to get the dirt out.” 
Participant four, male, age 20 years.
“Yes, with a pliers. And a string on the door. Me tooth cracked
and broke so I took the rest of it out.” 
Participant seven, male, age 40 years.
THEME THREE: Dental state 
Current dental state and oral health were described as important to
participants, with many participants regretting their prior neglect of
teeth and oral health, reflecting on their subsequent loss of
confidence, and emphasising the importance of personal outer and
dental appearance to them now when in recovery. 
Peer-reviewed
JOURNAL OF THE IRISH DENTAL ASSOCIATION
June/July 2014
146 : VOLUME 60 (3) 
“It is very important to me now as I am finished my addiction.
I realise they are important as I am missing lots of me back
molars and it is hard to chew food…. it builds peoples’
confidence to smile again. I think everyone is laughing at my
teeth.” 
Participant one, male, age 40 years.
“My teeth are very important for my physical appearance. My
teeth are now getting crooked and I might be getting
braces.” 
Participant three, male, age 26 years.
Many comments were made around missing, decayed, and
discoloured teeth. The majority of participants reported tooth loss
ranging from one tooth to 12 teeth. One participant described
avoidance of smiling so as not to draw attention to his discoloured
and absent teeth. Some reported intending to receive fillings and
teeth whitening in order to improve their aesthetics. 
“I am aware of them missing and it’s a horrible feeling. There’s
so many missing.” 
Participant one, male, age 40 years.
“The lowers are all stained and they look like they are gonna
fall out. Have just half a tooth too. I need to have teeth out
and I don’t want to get them out. I’m missing so many
already.” 
Participant four, male, age 20 years.
For the participants with children, personal neglect of dental care, and
awareness of repercussions, resulted in strong motivations to teach
good dental care (brushing, reduced sweet consumption, and routine
check-ups) to their children. 
“It will impact on them as I’m gonna make sure they floss and
look after them properly and I’ll bring them for six monthly
check ups as well, and so our children won’t have to suffer.” 
Participant one, male, age 40 years.
“All my kids have lovely teeth, they brush them every day, and
if there is something wrong I bring them straight to a dentist.
Their teeth are perfect.” 
Participant 12, male, age 46 years.
THEME FOUR: Consumption of substances and awareness of
potential for damage
Participants all reported awareness of the link between consumption
of sugary products and tooth decay. The consumption of sugary
products when actively drinking and/or drug using was described by
all participants. Current eating practices were described as healthier,
with less consumption of biscuits, sweets and sugary breakfast cereal.
Only half of participants reported awareness of alcohol’s potential to
increase tooth decay and demineralise tooth enamel. 
“Yes, I knew drink would fuck them up, but I didn’t know
about the enamel. I suppose it’s the same as fizzy drinks.” 
Participant four, male, age 20 years.
“I knew it was bad for your teeth, but I didn’t know it did that
much damage.” 
Participant seven, male, age 40 years.
All participants reported current rates of smoking, with age of onset
ranging from 10 to 23 years. All participants, with the exception of
two, reported awareness that tobacco can cause a wide range of oral
problems, such as delayed wound healing, sinusitis, soft tissue
damage, and gum disease. Some awareness of oral cancers relating to
tobacco was described. In terms of licit and illicit drug use,
participants described use of opiates, cannabis and stimulants, with
many partaking in poly substance use. All participants were aware of
dry mouth caused by drug use, but many were unaware of the causal
impact on tooth decay.
“Yeah, that’s what melted my back teeth - sucking on tablets.
Benzos [benzodiazepines], they wrecked my teeth.” 
Participant five, male, age 26 years.
Discussion
The study, despite its small scale nature, presents a unique insight into
the oral health behaviours of some recovering addicts attending
treatment in Ireland. Findings cannot be deemed representative of the
Irish situation, but do present illustrative and, to date, undocumented
accounts of drug user dental histories and interplay with drug and
alcohol dependence. Of concern is that only half of participants
reported routine dental visits as a child and thereafter, despite evident
strong current motivations to teach good dental care in their own
children. 
The study’s findings are supported by other studies,13,24-29 which
indicate the low uptake of dental services amongst individuals
experiencing problematic alcohol and drug use, addiction, and those
without permanent accommodation. Barriers to dental services
included lack of money or medical cards, and chaotic lives when
actively misusing alcohol and drugs. Similar to Robinson and Acquah,9
some participants described anxiety relating to fear of needles and
gloves. Levels of dental care in terms of brushing teeth and flossing
were described by most participants as neglectful in the past, with
some participants never brushing or flossing. Many participants were
regretful of their prior neglect of teeth and oral health. Similarly,
Gray40 has described how self-consciousness and guilt around dental
neglect impacts on the recovering addict’s self-perception, and
potential for employability, and stated “their teeth are a beacon to
their drug past”. Similar to the extant literature,7,9,13-16,21-24 participants
reported dental and oral health problems, which included: missing,
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broken or loose teeth; dental erosion; caries; gingivitis; and, bruxism,
with cases of DIY dentistry in the form of tooth extraction, use of
alcohol as mouthwash and the scraping of teeth with toothpicks
described, alongside the use of substances and toothpaste to
medicate for pain in the event of dental emergencies. Research has
suggested that drug users may have a low pain tolerance,41 thereby
exacerbating continued alcohol and drug use when experiencing
dental pain.13 Participants described some awareness of the direct
physiological effects of cigarette, alcohol and drug use, such as
reduced salivary function14-16 and the consumption of sugary
products4-6,8,10,12,17-19 on tooth decay, delayed wound healing,
sinusitis, soft tissue damage, gum disease, and oral cancers. 
On a positive note, routine dental care in the form of brushing and
flossing, and preventative dental service uptake improved when
attending the treatment and rehabilitation service. The study
narratives underscore how improved oral health, and the improved
appearance of teeth contribute to personal well-being, confidence,
and self-esteem when recovering from addiction.2,21,23-24
Research suggests that the situation of dental practices and
employment of oral health promotion initiatives in treatment and
rehabilitation settings offer promise in the facilitation of health
behaviour change, both for the addict and their children.9,32-34,42 The
findings offer a unique insight into the potential for development of
oral health promotion and preventative care activities for those
working with addicts in Ireland. Interventions developed in the UK
and US include: target leafleting by street outreach workers; free
mouth checks; integrated dentist and treatment services targeting
special groups at risk;7 dental ‘drop in’ clinics for active and recovering
drug users;2 and, outreach oral health promotion initiatives43 for street
drug users within a whole stakeholder community approach.44 The
proactive addressing of oral health needs, through screening,
prevention, diagnosis and treatment, can improve client morbidity
and well-being along the recovery continuum.44 Research in the UK
underscores the usefulness of collaboration between dental and
addiction service key workers, the service user involvement team, and
local pharmacies in the form of piloting dental drop in sites alongside
shared care services for service users with oral health promotion
central to building recovery capital.2,8,45 Equally, the study findings
can contribute the development of specific chemical dependence
training for Irish dental nurses and dentists in both private and general
dental practice.2,44,47
Conclusion 
The study highlights that, for those in recovery, specific dental
interventions in private and general dental practice would be received
positively. It presents a starting point in creating an oral health profile
of drug dependents in Ireland, with findings useful for the design of a
larger study at a later date. We recommend further research
investigating oral health status of clients attending addiction
treatment in Ireland, and the feasibility and acceptability of various
oral health care preventive strategies for use by public and private
dental practices. 
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The effect of flapless surgery on implant survival 
and marginal bone level: a systematic review and 
meta-analysis
Lin, G.H., Chan, H.L., Bashutski, J.D., Oh, T.J., Wang, H.L.
Background: The clinical outcomes of implants placed using the
flapless approach have not yet been systematically investigated.
Hence, the present systematic review and meta-analysis aims to study
the effect of the flapless technique on implant survival rates (SRs) and
marginal bone levels (MBLs) compared with the conventional flap
approach.
Methods: An electronic search of five databases (from 1990 to March
2013), including PubMed, Ovid (MEDLINE), EMBASE, Web of
Science, and Cochrane Central, and a hand search of peer-reviewed
journals for relevant articles were performed. Human clinical trials
with data on comparison of SR and changes in MBL between the
flapless and conventional flap procedures, with at least five implants
in each study group and a follow-up period of at least six months,
were included.
Results: Twelve studies, including seven randomised controlled trials
(RCTs), one cohort study, one pilot study, and three retrospective
case-controlled trials (CCTs), were included. The SR of each study
was recorded, weighted mean difference (WMD) and confidence
interval (CI) were calculated, and meta-analyses were performed for
changes in MBL. The average SR is 97.0% (range, 90% to 100%) for
the flapless procedure and 98.6% (range, 91.67% to 100%) for the
flap procedure. Meta-analysis for the comparison of SR among
selected studies presented a similar outcome (risk ratio = 0.99, 95%
CI = 0.97 to 1.01, P = 0.30) for both interventions. Mean differences
of MBL were retrieved from five RCTs and two retrospective CCTs and
subsequently pooled into meta-analyses; however, none of the
comparisons showed statistical significance. For RCTs, the WMD was
0.07, with a 95% CI of −0.05 to 0.20 (P = 0.26). For retrospective
CCTs, the WMD was 0.23, with a 95% CI of −0.58 to 1.05 (P = 0.58).
For the combined analysis, the WMD was 0.03, with a 95% CI of
−0.11 to 0.18 (P = 0.67). The comparison of SR presented a low to
moderate heterogeneity, but MBL presented a considerable
heterogeneity among studies.
Conclusion: This systematic review revealed that the SRs and
radiographic marginal bone loss of flapless intervention were
comparable with the flap surgery approach.
Journal of Periodontology. 2014; 85 (5): e91-e103.
Osteonecrosis associated with dental implants in
patients undergoing bisphosphonate treatment
Kwon, T.G., Lee, C.O., Park, J.W., Choi, S.Y., Rijal, G., Shin, H.I.
Objectives: Bisphosphonate-related jaw necrosis (BRONJ) associated
with dental implants is a rare but continuously reported complication.
To verify clinical and pathological characteristics of BRONJ around
dental implants, the present study analysed clinical, radiographic and
histopathological findings of these lesions.
Patients and methods: Nineteen patients were diagnosed with
osteonecrosis of the jaw associated with dental implants and treated
at our institute from 2008 to 2011. The patients’ medical history,
demographic features, radiographic, and histopathological findings
along with information on bisphosphonates (BP) administration were
analysed.
Results: The majority of BRONJ patients associated with dental
implants used oral BP for osteoporosis. The patients were divided into
two groups: BP initiation before (n = 16) and after (n = 3) implant
surgery. Only three patients (15.8%) could be regarded as “implant
surgery-triggered” BRONJ. Many patients (n = 9) showed successful
osteointegration after fixture installation to an average of 35 months
(11–82 months) until the development of osteonecrosis. The
histological features of the lesion showed that the necrotic bone with
empty lacunae was infiltrated by inflammatory cells and bacterial
colonies. Viable osteocytes were also observed in some areas of the
bony specimens. Three types of bone destruction pattern were
observed: (i) complete necrosis of the bone around the implant
(frozen type), (ii) extensive osteolysis around the implant with or
without sequestra (osteolytic type), and (iii) sequestration of bone
with an implant maintaining direct implant–bone contact (en block
sequestration type). These findings could be existed at the same
lesions depending on the degree of local bone destruction and the
severity of the infection.
Conclusion: These results and those of others suggested that already
osseointegrated dental implants can also cause the osteonecrosis
around the implant after BP administration. En block sequestration of
bone with implant might be one of the characteristics of implant-
related BRONJ, which is different from peri-implantitis-induced bone
destruction. The possible role of microcracks in this type of bone
destruction needs to be examined further. 
Clinical Oral Implants Research. 2014; 25 (5): 632–640.
Status of ten self-etch adhesives for bonding 
to dentin of primary teeth
Krämer, N., Tilch, D., Lücker, S., Frankenberger, R.
Objective: Aim of this in vitro study was to compare self-etch
adhesives regarding microtensile bond strength ( -TBS) to dentin of
primary teeth.
Methods: Fifty freshly extracted primary molars were ground to
expose caries-free dentin. Specimens were bonded with ten self-etch
adhesives (iBond self-etch/Heraeus, Xeno V+/Dentsply, G-Bond,
Gaenial Bond/GC, BeautiBond/Shofu, AdheSE One F/Ivoclar Vivadent,
Adper Easy Bond/3M ESPE, Clearfil SE Bond/Kuraray, OptiBond
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XTR/KerrHawe, Prime&Bond NT/Dentsply). After 24-h storage
(distilled water, 37°C), resin–dentin beams were cut and 848
resin–dentin sticks were subjected to -TBS tests. Fracture analysis was
carried out at 40× magnification under a fluorescence microscope and
under a SEM.
Results: Three adhesives (iBond SE, Clearfil SE Bond, Prime&Bond NT)
did not suffer pre-test failures (PTF). AdheSE One F revealed the largest
portion of PTF (28%; P < 0.05). Clearfil SE Bond and OptiBond XTR
exhibited more cohesive fractures than the other adhesives (77.3% vs
64.8%; P < 0.05). iBond SE, Gaenial Bond, Clearfil SE, and OptiBond
XTR achieved -TBS of >60 MPa, whereas Xeno V+ and AdheSE One F
ranged only at ~20 MPa (P < 0.05).
Conclusion: Within the limits of this study, the self-etch adhesives
under investigation proved different extents of initial -TBS to primary
dentin with iBond SE, Gaenial Bond, Clearfil SE, and OptiBond XTR
having been most successful.
International Journal of Paediatric Dentistry. 2014; 24 (3): 192–199.
The role of postoperative prophylactic antibiotics in 
the treatment of facial fractures: a randomised, 
double-blind, placebo-controlled pilot clinical study. 
Part 3: Le Fort and zygomatic fractures in 94 patients
Soong, P.L., Schaller, B., Zix, J., Iizuka, T., Mottini, M., Lieger, O.
The aim of this study was to evaluate the difference between the
effect of a five-day and a one-day postoperative course of antibiotics
on the incidence of infection after midfacial fractures. A total of 98
patients with displaced Le Fort or zygomatic fractures that required
operation were randomly assigned into two groups, both of which
were given amoxicillin/clavulanic acid 1.2g intravenously every eight
hours from the time of admission until 24h postoperatively. The five-
day group was then given amoxicillin/clavulanic acid 625mg orally
eight-hourly for another four days. The one-day group was given
placebo orally at the same time points. Patients were followed up
one, two, four, six, and 12 weeks, and six months, postoperatively.
The development of an infection of the wound was the primary end
point. Ninety-four of the 98 patients completed the study. Two of the
45 patients in the five-day group (4%) and 2/49 in the one-day
group (4%) developed postoperative wound infections. One in each
group had a purulent infection, while the others had only wound
breakdown. Two patients of the five-day group and one in the one-
day group developed rashes on the trunk. There were no significant
differences in the incidence of infection or side effects between the
groups. In midfacial fractures, a one-day course of antibiotics
postoperatively is as effective in preventing infective complications as
a five-day regimen.
British Journal of Oral and Maxillofacial Surgery. 
2014; 52 (4): 329-333.
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Quiz answers
1. What is the most likely cause of this woman’s pain?
This woman has shingles (Herpes Zoster). Shingles is a viral infection
of the nerve and affects the area of skin supplied by it. Early
symptoms include headache, fever and generally feeling unwell,
often followed, a few days later, by a painful skin rash. Pain in the
teeth may also feature. Herpes Zoster Ophthamicus (involving the
orbit of the eye) occurs in 10-25% of cases, caused by the virus
reactivating in the ophthalmic division of the trigeminal nerve.
2. What course of action would you take?
Swift action is crucial: immediate referral to a medical practitioner/
specialist, who will begin treatment with analgesics and antiviral
medications (Famciclovir 500mgs three times daily for seven days in
this woman’s case.) This will help prevent the virus from multiplying
and limit symptoms. In severe cases, shingles of the eye can lead to
inflammation of the whole eye, which may cause loss of vision. It can
also cause corneal scarring, which would necessitate a corneal
transplant, so the quicker treatment is commenced, the better.
Questions
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POSITIONS WANTED
Experienced dentist. Graduated 2000. Seeks part-time associate
position/sessions in Cork and commutable surrounds. All enquiries to:
associatecork@gmail.com.
POSITIONS VACANT
Associate position immediately available in south east to replace
departed colleague. Initially three days with view to extend. Modern
practice, computerised and digitial x-ray. Email:
dentistsoutheast@gmail.com. 
Dental associate required for one day a week - Wednesday/holiday
cover in a busy, modern dental surgery just one minute from exit 11,
M50. Please phone: 087 787 1648, or contact
wmunroe@eircom.net.
Associate dentist required in County Monaghan to replace departing
colleague. One/two days per week initially. Email:
shirleywright.7@btinternet.com. 
Full-time associate required for well-established, friendly, modern,
computerised practice in Dundrum, Dublin. State-of-the-art premises.
Minimum three years experience required. Email CV to:
jen@glenvilledental.ie. 
Part-time associate required for busy north-central Dublin practice.
Opportunity for the right person to build their book with skills and
personality. Fully computerised, small, friendly team with good
admin support, good patient mix. Email enquiries/CV to:
onemanorplace@eircom.net.
Experienced associate wanted to replace departing colleague at busy,
modern practice in Navan. Computerised, digital x-rays, OPT. Intra-
oral camera. Periodontist, implants, hygienist and experienced staff.
Two to three days/week with a view to full-time. Email:
gh@bridgeviewdental.ie.
Part-time associate required for new, fast-growing practice in Malahide,
awarded Most Attractive Practice at 2014 Irish Dentistry Awards.
Kindly contact us on: nicola@ivorydental.ie. 
New private surgery SW London requires part-time associate,
immediate start for the right person. Will wait for right dentist to
move from Ireland. Experience three years, must be warm and
friendly. Specialists welcome. CV and covering letter emails please:
enquiries@thewimbledondentist.co.uk. 
Associate required for Cork city practice starting September 2014.
Minimum three-years experience. Computerised with full support
staff. Email: corkcityassociate@gmail.com.
Full or part-time associate position available in busy Dublin city centre
practice. Experience essential. Please email CV to:
dentalrole@yahoo.com.
Associate required for busy west Dublin practice to replace departing
colleague. One to three days available immediately. Reply with CV to:
dentistrequired0@gmail.com.
Cork city southside. Part-time associate wanted initially for Thursday
evening and occasional Saturdays. No medical cards. 50% basis.
Email: airportdental@hotmail.com.
A part-time dental associate with at least three years experience is
required for two to three days in a busy practice in Ashbourne, Co.
Meath. Please apply by sending CV and references to:
peadar.ashdent@gmail.com.
Locum required for sessions in Dublin 6W practice for month of July,
with a view to long-term position. Busy practice with nurse and
reception staff. Min three years exp required. Please email CV to:
jobs@elitedental.ie.
Associate required in long-established, three-surgery private practice,
Dublin 14. Applicants with experience and a long-term view
preferred. Apply with CV to: southdubdentpractice@gmail.com.
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Classified advert procedure
Please read these instructions prior to sending an advertisement.
Below are the charges for placing an advertisement for both members
and non-members. Advertisements will only be accepted in writing
via fax (01- 295 0092), letter or email (fionnuala@irishdentalassoc.ie).
Non-members must pre-pay for advertisements, which must arrive no
later than July 14, 2014, by cheque made payable to the Irish Dental
Association. If a box number is required, please indicate this at the
end of the ad (replies to box number X). Classified ads placed in the
Journal are also published on our website www.dentist.ie for 12
weeks.
Advert size Members Non-members
up to 25 words €75 €150
26 to 40 words €90 €180
Non-members must send in a cheque in advance with their advert.
The maximum number of words for classified ads is 40. 
Only if the advert is in excess of 40 words, then please contact:
Think Media
The Malthouse, 537 North Circular Road, Dublin 1. 
Tel: 01-856 1166 Fax: 01-856 1169 Email: paul@thinkmedia.ie
Please note that all classified adverts MUST come under one of the
following headings:
4 Positions Wanted
4 Positions Vacant
4 Practices for Sale/To Let
4 Practices Wanted
4 Unwanted/Second Hand Equipment for Sale
Classified adverts must not be of a commercial nature. All
commercial adverts must be display advertisements, and these can
be arranged by contacting Paul O’Grady at Think Media, Tel: 01
856 1166.
Dentist required in south county Dublin practice, for one or two days at
the end of May beginning of June 2014, for approximately six weeks.
Email: dentsurg1@gmail.com.
We are looking for a dentist to replace a Tuesday-Friday and every
second Saturday list from September 2014 - January 2015 to cover
maternity leave. Position may then have potential to offer a part
time/full time position thereafter. Email: audrey@molesworthclinic.ie.
Enthusiastic dentist required for sessional work at a modern practice
with digital imaging and a highly trained back up team in Dublin 16.
Please email: kbmdental.grange@gmail.com.
Dentist required for state of the art clinic in Dublin 2. Must have at least
five years experience. Please email CV to:
carol.moroney@redmondmolloy.ie. 
Experienced dentist wanted for busy, well-established dental practice in
Co. Louth. Excellent long-standing support staff. April start. Email:
susie@smiles.ie. 
South East/Kildare requires a dentist part time Monday to Thursday
8.30am to 5.30pm. Email: loretodentalsurgery@gmail.com. 
Dentist wanted for established, busy Saturday book in an entirely private
practice in Co. Meath. On-site periodontist and endodontist, superb
level of equipment and excellent staff. Please reply with CV to:
abbeydentists@hotmail.com.
Tuam, Co. Galway: Full-time locum dentist required for maternity leave
August 2014. Fully computerised, digital radiography, rotary endo,
CEREC Omnicam, implantology, intra-oral camera. Excellent support
staff, hygienist and lab. Please submit CV to:
reception@abbeytrinitydental.ie.
Locum required for busy surgery in south east, just over one hour from
Dublin. Cover is for one week from June 9. Email:
rollywoods@hotmail.com.
Experienced locum dentist required for four to six weeks from mid July.
Busy modern practice with hygienist. Tramore, Co. Waterford.
Contact: bridcantwelldental@gmail.com.
Galway – locum dentist required to cover maternity leave August 2014
for six months. Email: charles@irishdentist.com.
Locum required, either part or full-time for a period of up to 10-12
months. Busy practice in Co. Wicklow with a high private proportion.
For further information please email: stu.lotte@hotmail.co.uk, or
phone: 085 7855120, 059 6482749.
Locum required for busy Dublin city centre practice for June. Please
email CV to: dentaldublin@gmail.com.
Locum required for busy, thriving practice in Co. Tipperary . Minimum
three years experience. Computerised practice, digital x-ray, modern
fully-equipped surgery with excellent support team. For further
information contact Linda at: 087 228 1282 or
lindaryan001@gmail.com.
Orthodontist required to do sessional work at a busy practice in Dublin
16. We are a modern practice with digital imaging and a highly-
trained back-up team. Email: kbmdental.grange@gmail.com.
Dental nurse required for busy general dental practice within a specialist
practice setting. Stephen’s Green area. Email:
Info@harcourtdentalclinic.ie, or practiceadmin@woolfedwyer.com.
Part-time dental nurse required for busy dental clinic Leixlip area.
Experience desirable and be able to work well as part of a team.
Please email CV to: reception@rfdentalclinic.com.
Dental nurse (experienced) required for full-time position in Glanmire,
Cork. Starting May 2014. Email CV to: squiresgary@yahoo.co.uk. 
Part-time dental receptionist required for busy dental clinic Leixlip area.
Candidate must have experience and be able to work well as part of
a team. Please email CV to: reception@rfdentalclinic.com.
Experienced dental nurse required for part-time position in busy
Limerick dental practice. Please send your CV to:
limerickdentjob@gmail.com.
Fully-qualified dental nurse required to work full time in a busy practice
in Cork city. Computer literacy and good people skills are required.
Available to start immediately. Please send CV with photo to:
corkdentalpractice@gmail.com.
Part-time hygienist required for busy, modern, progressive,
computerised practice in New Ross. Applicant must be confident and
motivated and must possess good interpersonal skills. Position is for
Thursdays/Fridays and is permanent €34/hr worked. Email:
dillondental2@gmail.com.
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CONTINUED OVERLEAF
SEPTEMBER
Munster Branch AGM
September 10 Maryborough House Hotel, 8.00pm.
Third World Congress of Clinical Safety (3WCCS) 
September 10-12 University of Cantaberia, Spain
Main theme: Clinical risk management. For further information see
http://www.iarmm.org/3WCCS/.
Munster Branch Meeting
September 15 Maryborough House Hotel
Strategies for providing care for patients with neurological disorders.
Speaker is Dr Alison. 
Mouth Cancer Awareness Day
September 17
IAAGDS Annual Meeting
September 27 9-00am – 1-00pm Radisson Blue Hotel, Dublin 8
Annual Conference of European Prosthodontic Association
September 25-27 Istanbul, Turkey
For further information contact info@ipa2014.org.
Infection Prevention 2014
September 29 – October 1 SECC Glasgow
The UK’s largest infection prevention and control event. To register,
contact www.ips.uk.net. Further information: ipsconf@fitwise.co.uk.
OCTOBER
Munster Branch Meeting 
October 9 Maryborough House Hotel
New generation orthodontic materials – what does the future hold?
Speaker is Dr Gerry Buckley.
HSE Dental Surgeons Seminar 2014
October 16 and 17 Mount Wolseley Hotel, Tullow, Co Carlow
Faculty of Dentistry RCSI Annual Scientific Meeting 2014
October 30-31 RSCI Dublin
For further information email facdentistry@rcsi.ie.
NOVEMBER
Munster Branch Annual Scientific Meeting
November 21 Fota Island
Diary of events
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Computerised, modern, busy practice in Cork is hiring a dental
Hygienist with great interpersonal skills. This part-time position is
available immediately; three days per week. Email letter and CV with
photo to: corkdentalpractice@gmail.com.
Full-time hygienist position available for busy dental practice in
Westmeath. Immediate start. Please email:
hygienistwestmeath@gmail.com.
A full-time dental receptionist is needed to cover maternity leave for
eight months from the last week of May 2014. Excellent
interpersonal skills and computer literacy are essential. Please send
CV to: swordsdentalreception@ gmail.com.
Locum dentist required for two-to-three days per week in Newry from
June to August. Please contact Michael at
info@gentledentalclinic.com.
Experienced locum dentist required for busy practice for last two weeks
in July/first week in August and also for one week in September.
Flexible on days worked. Contact Laura by email at
kingscourtdentalpractice@ gmail.com.
Locum Dentist required for holiday leave July 18-July 25 in friendly
modern practice.  30 mins from Limerick/Ennis and Nenagh. Tel 086
2871468
PRACTICES FOR SALE/TO LET
For sale - South Dublin. Four miles from city centre. Top class location.
Excellent footfall. Two well-equipped surgeries. Ripe for expansion,
extra room available. Medical card half national average. Walkinable.
Good figures. Speedy sale required. Tel: 00 353 86 807 5273. Email:
niall@innovativedental.com.
Practice for sale - south county Dublin. Single-handed practice located
in busy private medical centre. New equipment, computerised,
expansion possible. Lease will be considered. Email:
dentsurg1@gmail.com.
Single-chair practice for sale 5km from Dublin city centre. Low-cost,
low stress with good mix of patients. Over 50y established, fully
functional but some TLC needed. Please text or ring 087 337 9403
for details. Email: terof2001@yahoo.com.
For sale - north Dublin. Busy, fully private. Prestigious location. Three
surgeries leasehold. Excellent equipment. Fully computerised, OPT
LSkull. Expansion possible. High visibility. Large footfall.
Architecturally designed, walkinable. Ample free parking. Good
turnover. Large potential. Speedy sale required. Email:
niall@innovativedental.com. Tel: 086 807 5273.
For sale - Busy two surgery practice in Clane, Co. Kildare, easy
commute from Dublin. Excellent location with medical practice in
same facility. Predominantly private. Parking available. Enquires to:
paddy@malone.ie, if not already sold.
PRACTICES WANTED
Practice wanted Cork south/central. Single or double-handed with
expansion possible preferred. Hygienist, parking, low medical card
preferred. Confidentiality assured. Finance in place. Email:
dentist@irishinternet.com.
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